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INTRODUCTION 
 
The human body is estimated to be composed of more than 10
14
 
cells of which only 10% of the entire composition is of mammalian 
origin. Microorganisms form the major composition of cells that are 
found in our body, forming a resident microflora, surviving via a 
symbiotic relationship with the host and thus maintaining 
homeostasis
7
.
 
           The oral cavity of the human body contains a number of 
different habitats, including the gingival sulcus, teeth, tongue, cheeks, 
hard and soft palates, and tonsils, which are colonized by bacteria. The 
oral microbiome is comprised of over 600 prevalent taxa at the species 
level, with distinct subsets predominating at different habitats, this was 
stated by Floyd E. Dewhirst. It displays the largest core of commonly 
related microbes among unrelated subjects when compared to the 
microflora found in the gut or on our skin. The relationship between 
periodontal microflora and the host is known to be benign, but changes 
in the salivary microbiome and bacterial community structures can tilt 
the scales and cause a disruption in the symbiotic relationship, thereby 
leading to the pathogenesis of periodontal disease. 
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Microbial shift, more commonly known as dysbiosis, refers to 
the concept that some diseases are due to a decrease in the number of 
beneficial symbionts and an increase in the number of pathogens
20
. The 
long-standing paradigm is that, as periodontitis develops, the oral 
microbiota shifts from one consisting primarily of gram-positive 
aerobes to one consisting primarily of gram-negative anaerobes 
94
. 
Research over the past decade has led to recognition of 
microbes residing in various oral ecological niches as a part of dental 
plaque. Plaque biofilm is a highly organized accumulation of microbial 
communities adhering to favourable environmental surfaces, which 
functions to maximize energy, spatial arrangements, communication, 
and continuity of bacterial communities 
38
. The origin, development 
and structural adaptation of dental plaque is governed by a dynamic, 
ever-changing equilibrium between oral microbiota and multiple 
factors that differentially promote or inhibit survival of its microbial 
constituents.
 
Based on the earlier studies conducted by Socransky et al 
83
, 
the key bacterial species which play a role in the disease process have 
been segregated into microbial complexes based on their correlation 
with clinical parameters and severity of periodontal disease.  
Currently, the pathogenesis of periodontal diseases is explained 
by “Polymicrobial Synergy and Dysbiosis (PSD) Model” proposed 
by Hajishengallis et al 
20
. This model states that dysbiotic 
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environment and polymicrobial synergy are the key events that led to 
development of periodontitis rather than individual bacterial species.  
                       Technological research led to advancements in DNA 
sequencing and bioinformatics tools which later led to the development 
of the Omics technologies. It was observed that every individual has a 
specific microbiome and a metagenome that is unique and specific to 
that person. The development of 16s rRNA and subsequently the Next 
Generation Sequencing technologies led to further characterization of 
the microbiome 
57 
                       Human Oral Microbiome Database (HOMD) is software that 
currently lists the entireset of organisms present in the oral cavity as a 
whole. Several ecological niches have been identified within the oral 
cavity, each with its very own distinct microbiome 
17
. 
  Sampling fluids from the oral cavity, instead of other bodily 
fluids like blood or urine, provides an accessible medium in which a 
range of candidate biomarkers, such as electrolytes, proteins, 
antibodies, hormones and DNA/RNA, as well as other substances such 
as therapeutic drugs can be detected. While oral fluid assessment has 
been suggested to be useful in screening for or diagnosing oral or 
systemic diseases, monitoring viral or fungal infections, there is a lack 
when it comes to detecting drug exposure, and evaluating endocrine 
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disorders and cancer risk, evidence of utility for most of these purposes 
is lacking. 
 
         There continues to be interest in oral fluid as a diagnostic 
medium for rapid, point-of-care testing. Potential advantages of using 
saliva for disease diagnostics include the sample collection in toto 
being an easy and noninvasive procedure which thereby increases 
patient compliance, and there is a decrease in the risk of infectious 
disease transmission. Readily accessible fluids include: whole saliva, 
secretions from specific glands, mucosal transudate, or gingival 
crevicular fluid. Although various methods of collecting saliva and 
other oral fluids affect the precision and determination of biomarkers 
of interest, to date, there are no established uniform criteria available 
for the collection of human saliva 
29, 35
. 
         Dental implants are made of materials which are biocompatible 
with the host tissue, which when placed in the alveolar bone provide 
anchorage and support to the prosthetic superstructure that is 
fabricated. Peri-implant tissues are only thought to be of microbial 
origin and closely to parallel to periodontal diseases in the form of 
etiopathogenesis. However there is still some ambiguity in literature 
about the microflora in implants when compared to tooth. 
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      Development of alternative methods instead of the traditional 
culturing methods has led to assess dental biofilms based on DNA 
analysis or other molecular techniques. Studies of salivary microbial 
community identified a link between taxonomic composition and 
disease pathogenesis. Current trend in sequencing of microbiome is 
based on Next-Generation Sequencing (NGS) that uses parallel 
sequencing of multiple small fragments of DNA to determine genetic 
sequences.  
          NGS technology was utilized earlier in our department 
(unpublished data) to identify and characterize subgingival microbiome 
from periodontal pockets and gingival recession. 
        Salivary microbial profiling may be a promising method of 
identifying further disease progression in both periodontitis and peri-
implantitis. In this regard, the salivary microbiome in periodontal 
health and in healthy implant sites must first be established. 
        For a better understanding and in an attempt to analyze and 
characterise the salivary microbiome in periodontal health and in 
healthy implants six months post loading using Next Generation 
Sequencing Technology, the current study was undertaken.  
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AIM AND OBJECTIVES 
 
Aim:  
To determine salivary microbiome using NGS technology in patients with 
implant supported prosthesis placed (6 months post loading). 
 
 
Objectives: 
1. To identify and characterize the salivary microbiome in patients with 
implant supported prosthesis placed (6 months post loading) using 
Next Generation Sequencing Technology. 
2. To compare and analyze the salivary microbiome in sites of in patients 
with implant supported prosthesis placed (6 months post loading) with 
those of periodontally healthy controls. 
3. To study species diversity in salivary microbiome, and characterize 
novel micro-organisms in in patients with implant supported prosthesis 
placed (6 months post loading). 
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REVIEW OF LITERATURE 
The human body is an entire living organism as a whole composed of various 
cells that combine together to form tissues which in turn lead to the formation 
of organs. Microorganisms are present all over our body and they contribute to 
the majority of cells that are found in our body, thereby forming the resident 
micro-flora and survive by having a symbiotic relationship with the host, 
thereby maintain homeostasis 
41, 73
. 
The oral microbiome 
The human body is estimated to have10⁴ cells, out of which only 10% are of 
mammalian origin 
70
. The oral microbiome is completey unique and distinctive 
due to its characteristic physical and biological abilities and the properties 
associated to each site despite the potential movement of micro-organisms 
between sites. They have the ability to attach to tooth surfaces or the epithelial 
surfaces of the gingiva and periodontal pocket. Combining these key 
observations led to the formulation of a core concept that illustrated the 
properties of the habitat are selective and dictate which organism are able to 
colonise, grow and whether they are minor or major members of the 
community 
25, 93  
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The Germ Theory 
The germ theory of disease is the scientifically accepted current concept of 
disease. It states that, the main causes of many diseases are micro-organisms. 
These small organisms, microscopic in nature, invade the human cells, animal 
cells, and other living hosts. Their ability to grow and reproduce within the 
host cells can cause a disease. "Germ" doesn‘t just refer to bacterial origin but 
to any type of microorganism, especially one which causes disease, such as 
fungi, viruses, protozoa etc. 
Microorganisms that cause diseases are classified under the term 
―PATHOGENS‖. The diseases they cause are of an infectious nature. Even 
when a pathogen is the principal cause of a disease, other factors like 
environmental and hereditary often influence the severity of the disease, and 
whether a potential host individual becomes infected when exposed to the 
pathogen. 
The germ theory was proposed by Girolamo Fracastoro
33, 43, 123
 in 1546, and 
expanded upon by Marcus von Plenciz 
82 
in 1762. Even though the theory 
was established, it was not popular among the practising doctors and scientists 
during the day, they still followed Galen's miasma theory 
49
. The drawback of 
this belief in the theory prevented them from understanding how diseases 
actually progressed, with predictable consequences. By the early nineteenth 
century, smallpox vaccination was common among the practioners in Europe, 
though doctors were unaware of how it worked or how it‘s principles extended 
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to other diseases. Viruses were later discovered in the late 1800s sometime 
around 1890. 
 
The Miasma theory 
The miasma theory was the most common theory of disease followed in the 19 
the century before the establishment of germ theory. It stated that diseases 
such as cholera, chlamydia infection, or the Black Death were caused by a 
miasma (Ancient Greek: "pollution"), a noxious form of "bad air" emanating 
from rotting organic matter.
 
The theory posited that diseases were the product 
of environmental factors such as contaminated water, foul air, and poor 
hygienic conditions. Such infections, according to the theory, were not passed 
between individuals but would affect those within a locale that gave rise to 
such vapours.
 
Robert Koch and his Postulates 
Robert Koch is known for develop Koch's postulates that demonstrated, in a 
scientifically sound manner, that a disease is usually caused by a particular 
organism. These postulates were formulated from his work with anthrax using 
purified cultures of the pathogen that had been isolated from diseased animals. 
Koch's postulates were developed to serve as guidelines as to which pathogens 
can be isolated in the treatment of a disease in the 19
th
 century. In the 1980s, a 
Review of Literature 
 
10 
 
molecular version of Koch's postulates was developed to guide the 
identification of microbial genes encoding virulence factors. 
Koch's postulates: 
1. The microorganism must be found in abundance in all organisms 
suffering from the disease, but should not be found in healthy 
organisms. 
2. The microorganism must be isolated from a diseased organism and 
grown in pure culture. 
3. The cultured microorganism should cause disease when introduced 
into a healthy organism. 
4. The microorganism must be re-isolated from the inoculated, diseased 
experimental host and identified as being identical to the original 
specific causative agent. 
Socransky’s criteria 
Proposed a criteria by which periodontal microorganism can be classified as a 
periodontal pathogen based on checkerboard DNA technique, he later 
classified the different colour complexes of the bacteria based on their time of 
colonization
83, 106, 108 
1. Must be associated with disease, as evident by increase in the number of 
organisms at diseased sites 
2. Must be eliminated or decreased in sites that demonstrate clinical 
resolution of disease with treatment 
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3. Must demonstrate a host response, in the form of an alteration in the host 
cellular or humoral immune response. 
4. Must be capable of causing disease in experimental animal model. 
5. Must demonstrate virulence factors responsible for enabling the 
microorganism to cause destruction of periodontal tissue 
109 
  
 
Dental Implants 
Dental implants have become an indispensable and in vogue form of therapy 
in dentistry in order to replace missing teeth in different clinical situations. 
With success rates as high as 82,9% 16 years post loading have been reported. 
With careful attention to the indications, anatomical and also keeping in mind 
the intra-individual limiting factors, insertion of dental implants seems to 
represent itself as ―safe‖ modality when it comes to the treatment option of 
replacing missing teeth 
42, 43
. Nevertheless, in the last few decades increasing 
evidence have been raised on the presence of peri-implant inflammations 
55, 57
. 
It is being represented as one of the most frequent complications affecting 
both the surrounding soft and hard tissues which can lead to the loss of the 
implant. Therefore, strategies for prevention and treatment of peri-implant 
disease should be integrated in modern rehabilitation concepts in dentistry 
50
.  
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Peri-implant Tissues and Peri-implant Diseases 
The soft tissue surrounding a dental implant is termed as the peri-implant 
mucosa while the soft tissue surrounding a tooth is known as the gingiva. 
Although there are similarities between these two types of tissues, they have 
differences among each other present at a histological level 
69
. The soft tissue 
present around an implant consists of keratinized and non-keratinized 
epithelium, similar to that of the periodontal tissues around the natural tooth. 
Unlike the natural tooth, there is an absence of the periodontal ligament 
between the implant and the surrounding bone, and the implant-bone contact is 
directly supplied, and is not done not via the fibers 
104
. 
Because the dental implants placed in the oral cavity are in direct contact 
with the bone, the forces applied cannot be compensated. In addition, the peri-
implant tissues are devoid of mechanoreceptors in the periodontal region that 
which are crucial when it comes to recognize the sense of touch. 
      Pathological changes that occur in the tissues that surround the implant are 
called peri-implant diseases. If these inflammatory changes are limited only to 
the soft tissues, they are known as peri-implant mucositis and they are called 
peri-implantitis only when the disease spreads to the underlying alveolar 
bone
2, 4
. In a systematic review published by Derks et al. in 2015 
20
, the 
prevalence of the condition called peri-implant mucositis was reported to be 
between 19% and 65%, and the prevalence of peri-implantitis ranged 
betweeen 1% to 47%. 
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Mucositis is a term that describes a bacteria-induced, reversible inflammatory 
process of the peri-implant soft tissue with reddening, swelling of the soft 
tissue and also bleeding on periodontal probing. 
   In contrast to mucositis, peri-implantitis is a more progressive and 
irreversible disease of the hard and soft tissues surrounding an impalnt and is 
accompanied usually with bone resorption and decreased osseointegration 
along with increased pocket formation and purulence. After the insertion of 
titanium implants, within the peri-implant sulcus, rapid colonization of 
bacteria has been observed
127
. Some microbiological studies have shown that 
implants affected by peri-implantitis tend to harbour microbiota consisting of 
the key periodontal pathogen species, including Porphyromonas gingivalis, 
Aggregatibacter actinomycetemcomitans, Tannerellaforsythia, Prevotella 
intermedia, and Fusobacterium species. 
Clinically, typical symptoms associated to peri-implant infections are: redness, 
oedema and bleeding observed in the soft tissues in the peri-implant mucositis. 
In peri-implantitis patients, clinical findings such as an increase in probing 
depth values and detection of radiographic bone loss are usually added to the 
already present clinical symptoms 
14
. The etiology of peri-implant diseases and 
the etiology of periodontal diseases are similar. However, the fact that there is 
no real fibrous connective tissue attachment around the implants as it is in the 
teeth makes the tissues around the implant makes it more sensitive to 
microbial attack. Bacterial infection has a very important role in the success of 
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dental implants. In clinical and animal studies, bacterial plaque accumulation 
around the implant caused inflammatory reaction in peri-implant tissues. 
Microbial etiology of Peri-implant diseases 
Considering that the infectious nature of peri-implantitis is caused by the 
accumulation of a complex biofilm community on the implant surface, it 
seems sensible to try to map out the microbial profile of this disease. However, 
till date any hope of finding out what the actual cause of a peri-implant 
infection is still not a reality
17
. This has happened far earlier for periodontitis, 
and a lot of common lessons apply for both pathological entities. Therfore, the 
fundamental principle that is applicable for periodontitis can be used for peri-
implantitis as well, i.e. peri-implantitis like periodontitis it is an opportunistic, 
endogenous, polymicrobial infection. This implies that the pathological 
species associated with the destructive disease are parts of the normal oral 
microbiota, but under certain ecological shifts (dysbiosis) become pathogens, 
never alone, but always acting in synchrony. It is not the mere presence of 
specific bacteria instigating the disease origin rather it‘s the interplay of 
divergent abundant bacteria from different phyla. 
Over the years different methods have been applied to characterize the peri-
implant microbiota. Culture-dependent methods have traditionally been the 
gold standard, but now molecular methods have been introduced to avoid 
conventional time-consuming laboratory work. With the new millennia, 
sequencing methods have started to take over the industry, including the latest 
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next-generation sequencing, have emerged to reveal in more detail differences 
between healthy and diseased oral microbiomes
 17
. 
Bacterial colonization on the implant surface starts 30 min after insertion, and 
similar bacterial taxa can be identified on the implant after several months. 
The bacterial composition of the biofilm formed and observed on implants is 
similar to that of the adjacent teeth 
30
. Hence, the microbial flora found on 
natural teeth are actually ‘‘a reservoir’’ for the biofilms that build-up around 
implants. In respect to the initial (i.e. 4 weeks) subgingival colonization, the 
frequency of detection of different species is similar between that of natural 
teeth and implants. Nevertheless, the colonization pattern on implants appears 
to be initially slower than on natural teeth. The peri-implant microflora in 
health consists mainly of Gram-positive cocci and non-motile bacilli, and a 
limited number Gram-negative anaerobic species, resembling gingival health. 
Nevertheless, the switch to peri-implant mucositis is associated with an 
increase in the presence of cocci, motile bacilli and spirochetes, at proportions 
comparable to gingivitis. The transition to peri-implantitis is associated mainly 
with the emergence of Gram-negative, motile, and anaerobic species that are 
commonly found in periodontits 
52, 65
. 
Based on clinical studies it was observed that while the three ‗‗red complex‘‘ 
species, namely Porphyromonas gingivalis, Tannerella forsythia and 
Treponema denticola, can be found at higher counts in peri-implantitis. 
Collectively, it appears that the qualitative composition of the biofilm 
microflora in peri-implantitis resembles that of periodontitis, this inturn 
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implies to the fact that patients with active periodontal disease are at higher 
risk for developing peri-implantitis. Submucosal biofilms obtained from peri-
implantitis patients also yield bacteria that display in-vitro resistance to one or 
more standard antibiotic treatments. These are most often Prevotella 
intermedia/nigres-cens or Streptococcus constellatus. 
Nevertheless, a number of microorganisms have been identified in peri-
implantitis patients that are not commonly observed in patients with 
periodontitis
 32
. These include bacterial species such as Staphylococcus 
aureus, Staphylococcus epidermidis, Enterobacter aero-genes, Enterobacter 
cloace, Escherichia coli, Helicobacter pylori, Peptostreptococcus micra, 
Pseudomonas spp, as well as Candida spp fungi. Presence of S. aureus shortly 
after implant insertion can be confirmed even one year later. It has also been 
shown that up-to 18.6% of peri-implantitis lesions harbour aerobic Gram-
negative bacilli, such as enteric rods and coliforms, or non-enteric rods, but the 
microbial concentration may not fully correlate to the severity of the disease. 
Putative periodontal pathogens may be detected at higher levels, prevalence 
and numbers, than in fully edentulous patients. Early studies indicated absence 
of detection of Aggregatibacter . 
Higher roughness and higher free energy of the implant surface may favour 
biofilm formation, whereas peri-implantitis may occur earlier, with a faster 
and more extensive progression in implants with rougher surface. 
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In this respect, potential differences in bacterial adhesion due to surface 
microstructure may partially be equilibrated by the mediating salivary pellicle. 
Hence, given the biological involvement of the pellicle, implant surface 
characteristics may not notably affect the initial stages of biofilm formation 
and composition. 
Peri-implant Tissue Microbiology 
Peri-implant diseases after successful osseointegration of intra-bone 
implants are caused by an imbalance between bacterial activity and host 
response. The response to inflammation in peri-implant diseases may be 
confined to the mucosa around the implant as it is in the peri-implant 
mucositis, or it may progress and cause loss of bone tissue and lead to peri-
implantitis
72
. 
Periodontal and peri-implant diseases are infections caused by 
microorganisms. Therefore, the use of microbiological parameters has an 
important role in both microbial development and routine diagnosis and 
follow-up. It has been reported that periodontal pathogens are detectable 
around dental implants that begin to function in the oral environment in a short 
period of a month
79
. 
After implant placement perioodontopathogens are found present in healthy 
microflora. Koka et al.
36
 in his study observed the existence of P. gingivalis, 
P. intermedia, Actinomyces naeslundii, F. Nucleatum and T. denticola in the 
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plaque samples on the 14th and 28th days after opening of the implant into the 
oral environment was investigated in comparison with natural teeth. 
 According to the data that was obtained, these species can be determined after 
14 days and within 28 days; a complex salivary microbiota has been reported 
to colonise the site . Although there are only a few changes in the microbial 
species profile around the tooth, there has been a significant increase in the 
amount of F. nucleatumss vincentii, Peptostreptococcus micros, Prevotella 
nigresence and P. Gingivalis species around the implant over time. The 
species such as S. mitis and S. oralis seen in early colonization on teeth were 
also colonized at the second week around the implants and maintained their 
levels for 26 weeks. It has been reported that in the salivary flora of clinically 
healthy implants, there is a high proportion of bacteri a in the form of cocci, 
and that spirochetes, motile bacilli and Gram (-) anaerobic species are none or 
low. It has been reported that there is a high rate of spirochetes and motile 
bacteria in clinically deep pockets and implants with increased alveolar bone 
loss
 79
. 
Periodontopathogenic bacteria such as porphyromonas gingivalis, treponama 
denticola, tannerella forsythensis and aggregatibacter actinomicetocomitans 
have been shown to be similar in peri-implant pockets and in periodontal 
pockets. 
Leonhardt et al.
39, 41
compared microbial flora found in the vicinity of healthy 
implants with the one in implants where peri-implantitis observed, they 
reported that in the study group 60% of the implants were detected with P. 
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gingivalis, P. intermedia, A. actinomycetemcomitans and P.nigressence with 
55% Staphylococcus spp., enteric and Candida spp. and none of these 
microorganisms were detected in the healthy group. 
Implant loss can be differentiated on the basis of the following additional 
factors: 
  Overloading of the implant, 
  Faults in material and techniques, 
  Poor bone quality at the implant area, 
  Systemic diseases and drug therapies, which inhibit bone modulations 
according to ―Wolff‘s law‖ (bone density and strength increase with 
stress - and vice versa). 
Thus, implants of more than 10 mm length in square thread design show 
higher success rates than shorter implant lengths or shapes without thread or 
buttress thread
 62, 65
. Also rough implant surfaces of more than 2 microns seem 
to feature better osseointegration than smooth (<0.5 microns) or moderate 
surfaces (1–2 microns) 105 
Mechanical overload in implants 
Occlusal trauma in an implant patient may be defined as an injury to apparatus 
used as an attachment is the result of excessive occlusal force directed to the 
apparatus. There is a current controversy regarding the role of occlusion in 
respect to the amount of bone loss observed after the delivery of animplant 
prosthesis 
112
. 
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There is generalized consensus that was made in respect to the fact that early 
implant failure may be associated with overload. However, some articles 
conclude that peri-implant bone loss without implant failure is primarily 
associated with biological formations or complications 
1, 48
. 
Other authors suggest a correlation of crestal bone loss to occlusal overload. 
The relationship between ―stress and strain‖ determines the modulus of 
elasticity (stiffness) of a material 
67
. Hence, the modulus refers to the amount 
of dimensional changes that occur in a material for the given amount stress 
level. The modulus of elasticity of a tooth is similar to that of cortical bone. 
Dental implants are usually fabricated using titanium or its alloy. The modulus 
of elasticity of titanium is 5 to 10 times greater than that of cortical bone 
5, 8
. 
An engineering principle known as ―the composite beam analysis‖ states that 
when two materials of different elastic moduli are placed together with no 
intervening material, of which one is loaded, a stress contour increase will be 
observed where the two materials first come into contact. 
In the oral cavity when it comes to an implant-bone interface these said stress 
contours are of greater magnitude at the bone‘s crestal region 90. This 
phenomenon was observed in both photo-elastic and also a 3-dimensional 
finite element analysis studies when implants were loaded within a bone 
simulant. 
Bone Mechanical Properties 
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The density of bone is said to be directly related to the strength and elastic 
modulus of bone. Hence, in bone with higher density the amount of strain is 
lesser and experiences a lesser load when compared to softer bone 
68
. As a 
result, the amount of remodeling in denser boner is lesser compared to softer 
bone when they experience similar load conditions 
3
. 
A decrease in the amount bone remodeling can result in lower levels of bone 
loss. In a prospective human study, Manz observed that the amount of 
marginal bone loss observed next to an implant was directly related to the 
density of the bone. 
Hoshaw et al conducted a study in dogs where loaded threaded implants were 
placed in the oral cavity of the canines with a tensile load and he noted that the 
fine trabecular bone pattern became coarse trabecular bone around the implant 
98
. Fine trabecular bone is less dense when compared to coarse trabecular 
bone.  Since the density of bone is directly related to its strength and elastic 
modulus, the crestal bone strength and biomechanical mismatch between 
titanium and bone may improve in relation to the functional loading. In other 
words, the stresses applied to the peri-implant bone may be great enough to 
cause bone resorption during the first year, since bone strains are greatest at 
the crest. But the stress applied below the crest of bone is of less magnitude 
and may correspond to the physiologic strain, which allows the bone to gain 
density and strength 
103
. As a result, the occlusal load that causes bone loss 
initially (overload), is not great enough to cause continued bone loss once the 
bone matures and becomes more dense. 
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Implant Design Biomechanics 
Implant design may change the amount or type of forces applied to the bone-
implant interface
118
. A smooth collar at the crest module may transmit shear 
forces to the bone. Bone is observed to be strongest under compressive forces, 
30% weaker under tensile loads, and 65% weaker to shear forces. 
Bone may heal to the smooth metal collar of the implant crest module from 
implant insertion to implant exposure; but when under loading conditions, the 
weaker shear interface may be more inclined to overload the bone. The first 
thread of the implant is where the type of force changes from primarily shears 
to compressive and/or tensile loads. 
Therefore, in many situations the 35 to 65% increase in bone strength through 
changes from shear to compressive loads is sufficient to halt the bone loss 
process. This may be one of the reasons why implant designs with a 2 mm 
smooth collar above the first thread and a 4 mm smooth collar above the first 
thread, both lose bone to this ―first thread‖ landmark 12, 113. 
 
 
Factors of the implant affecting adhesion of bacteria on its surface 
Surface roughness 
Broad and detailed research shows that both the amount of plaque formation 
and the maturity of the plaque, with increasing numbers of motile rods, 
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increase in proportion to the roughness of the surface. Several studies have 
investigated roughness and bacterial adhesion by altering a titanium surface. 
According to a study conducted by Amoroso et al, the adhesion of 
Porphyromonas gingivalis, as a cause of periodontal disease, significantly 
declined on a ―very smooth‖ titanium surface, i.e., much smoother than the 
one commonly used as an implant abutment (Ra = 34.57 vs. 350 nm, 
respectively) 
6,119
. 
The dependence of bacterial adhesion on titanium surface roughness was 
confirmed in a recent in vitro study. 
Among three titanium disc surfaces, an acid-etched and blasted surface 
showed significantly higher roughness and proportionately higher adhesion by 
Streptococcus mutans, Porphyromonas gingivalis, and Fusobacterium 
nucleatum than either a machined or acid-etched surface. 
A recent study using an in vivo model evaluated the effects of titanium surface 
roughness on initial bacterial adhesion by Streptococcus sanguinis, 
Actinomyces naeslundii, and Lactobacillus salivarius. The rougher blasted 
surface, with a Sa of about 1.5 μm, showed greater bacterial adhesion than the 
turned surface, with an Sa of 0.18 μm. An anodicallyoxidized surface (Sa = 
0.4 μm) also promoted greater microbial attachment than the turned surface. 
The augmented resistance of the rougher surfaces to shear forces was 
suggested to cause the increased bacterial adhesion 
122, 135
. 
While bacterial adhesion declines as surface roughness decreases, there is a 
lower limit to this relationship, at a roughness called the ―threshold Ra.‖ 
Bollen et al reported that there was no effect on the salivary microorganism 
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composition in the short-term or in the long-term when the Ra was < 0.2 μm . 
In that study, the authors connected the titanium abutment (Ra = 0.2 μm) to 
the fixture and sufficiently grounded the ceramic abutment (Ra = 0.06 μm) 
also to the fixture. After intraoral exposure of these setups for 3 and 12 
months, the clinical periodontal index and plaque samples were compared. 
Both the number and the composition of the pathogenic bacteria were found to 
depend on the roughness of the abutments, with an increase in probing depth 
and greater bleeding in response to probing determined on rougher versus the 
smoothest abutments 
7
. 
This result correalated with the results of an in-vivo study by Quirynen et al 
28
, who monitored the clinical and microbiological findings obtained with four 
grounded titanium abutments, with Ra values ≤ 0.2 μm, for 3 months. While 
spirochetes were observed only around the roughest of abutments, there were 
no other differences observed in salivary microbial population, providing 
further evidence of a said threshold level below which reduced bacterial 
adhesion doesn‘t confer a clinical benefit 13. Also, the results of this study 
showed that although some attachment gain (0.2 mm) was achieved in the 
roughest abutment, the other abutments had at least a minimum of 0.8 mm of 
attachment loss, indicating that a certain degree of roughness of surface is 
needed for providing a resistance against probing.  
Surface free energy (SFE) 
The technique called sessile drop is frequently used to determine the energy 
of solid surfaces. It involves the measurement of the contact angle between a 
droplet of liquid with a known surface energy and the solid surface of interest. 
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Because roughness is one of the several factors affecting the contact angle, 
roughness itself will affect the surface free energy (SFE).  
Busscher et al reported the surface roughness‘s effects on the contact angle 
disappeared when Ra was < 0.1 μm. Thus, while the SFE is independent of 
roughness below certain values of Ra, further experiments must be conducted 
to interpret this finding. 
Recent in vitro research has evaluated SFE and bacterial adhesion using disc 
samples whose surfaces consisted of a polished, partially stabilized zirconia 
material, (titanium blasted with zirconia, titanium blasted with zirconia, and 
then acidetched, or polished titanium). The surfaces of polished partially-
stabilized zirconia and titanium blasted with zirconia were found to have a 
lower SFE and decreased bacterial adhesion property (Streptococcus mitis and 
Prevotella nigrescens). The authors concluded that SFE is the most important 
factor determining initial bacterial adhesion. 
Bacterial adhesion was shown to correlate with the total SFE and the 
proportion of the nonpolar component of the material. These findings 
correlated with those of Pereni et al
73, 133
, in which an association between 
SFE and bacterial retention was demonstrated, albeit using other bacterial 
species. 
The SFE of the substratum is related to the SFE of the bacterial clusters. On 
low-SFE surfaces, bacterial clusters with lower SFEs were shown to be 
predominant. In addition to the SFE of the substrate and of that of the bacteria, 
that of the suspending medium is also important. In addition, the pellicle 
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coating was shown to have homogenizing effects on the SFE, indicating the 
complexity of SFE effects even under defined conditions. 
 
 
 
 
MATERIALS 
Titanium is commonly used as the abutment material because of its superior 
biocompatibility. Recently, however, zirconia has been increasingly preferred 
for esthetic reasons; thus, many studies have compared zirconia and titanium. 
The results of a study conducted by Scarano et al supported the use of 
zirconia. In that in vivo human study, an intraoral device adhered with either 
zirconia or titanium disc samples was exposed for 24 hours, after which the 
surface was analyzed with SEM to measure the rate of bacterial covering 
2 0, 59
. 
Significantly less adhesion was observed with zirconia (12.1%) than with 
titanium (19.3%), indicating the appropriateness of the former as an abutment 
material. 
Nonetheless, many researchers reported no differences between the two 
materials. Rasperini et al conducted a study in which a microbiological 
analysis of samples collected from titanium and zirconia abutments at 6 hours, 
24 hours, 7 days, and 14 days were done 
60,126
. Maximum colonization 
occurred after 24 hours of intraoral exposure and was maintained consistently 
until the 14th day, with no differences between the two materials. A similar 
study conducted by Brakel et al prolonged the observation period. Bacterial 
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composition and soft-tissue health at the second post-operative week and third 
post-operative month were not significantly different in the zirconia versus the 
titanium group. In an in- vitro study comparing pellicle composition and 
bacterial binding properties, zirconia and titanium yielded similar results that 
were significantly different from those obtained with hydroxyapatite
76
. 
 
A recent in vivo study compared dental ceramics with respect to biofilm 
formation. Glass ceramic, lithium disilicate glass ceramic, yttrium-stabilized 
zirconia (Y-TZP), pressed Y-TZP ceramic, and a pressed mixed ceramic with 
Y-TZP and 25% alumina, all with similar surface roughness (mean Ra = 0.04 
μm), were tested. Plaque accumulation was lowest in the pressed Y-TZP 
ceramic and highest in the lithium disilicate glass-ceramic, suggesting that the 
material itself also has an effect on biofilm formation, although this is partly 
related to its surface energy 
51, 133
. The use of a gold alloy as an abutment 
material analogous to the use of zirconia and titanium has been examined in 
several animal and clinical studies aimed at estimating its biological reliability 
by measuring the periodontal index and assessing soft-tissue stability.  
Salivary diagnostics 
Saliva and other oral fluids (for example: oral mucosal cellular secretions, and 
gingival creviculaxr fluid) support the health of the soft and hard tissues 
present in the oral cavity. The protective functions of saliva mainly include 
maintaining a neutral oral pH, cleaning and re-mineralizing teeth, facilitating 
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swallowing and digestion, and protecting oral tissue against desiccation and 
invasion by micro-organisms
76, 86
. 
Adequate saliva is essential for maintaining oral health, and reduced salivary 
secretion (i.e., hyposalivation) or xerostomia (i.e., dry mouth) can contribute 
to oral problems such as dental-caries, periodontal diseases,etc 
10
. 
There continues to be interest in oral fluid as a diagnostic medium for rapid, 
point-of-care testing.
 
Potential advantages of using saliva for disease 
diagnostics include ease of access, noninvasive sample collection, increased 
acceptance by patients, and reduced risks of infectious disease 
transmission. Readily accessible fluids include whole saliva, secretions from 
specific glands, mucosal transudate, or gingival crevicular fluid
36, 39
. 
Although various methods of collecting saliva and other oral fluids affect the 
precision and determination of biomarkers of interest, to date, there are no 
established uniform criteria for collection of human saliva
19, 67
. 
Currently, oral fluid testing by clinical laboratories is regulated under the 
Clinical Laboratory Improvement Amendments of 1988 (CLIA).  
 
Oral Fluid Bio-components 
 
Bio-component Class Examples 
Hormones Cortisol, androgens, estriol, estrogen, progesterone, 
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aldosterone, melatonin, insulin 
Cytokines 
Interleukins (IL-1beta, IL-6, IL-8), tumor necrosis 
factor, troponin 
Antibodies IgG, IgA 
Proteins/Enzymes 
Amylase, pepsin, matrix metalloproteinases, C-
reactive protein (CRP), mucins, lactoferrin, 
antimicrobial peptides 
Growth Factors 
Epidermal growth factor (EGF), vascular endothelial 
growth factor (VEGF) insulin-like growth factor 
Nucleic Acids 
Human and microbial DNA, mRNA, microRNA, 
tRNA-derived small RNA (sRNA) 
Viruses HIV, HSV-1, HSV-2, EBV, HPV, CMV, VZV, HCV 
Bacteria 
P. gingivalis, S. mutans, Lactobacillus spp, T. 
forsythia, E. coli, H. pylori, M. tuberculosis 
Fungi Candida, Aspergillus 
Drugs 
Anticonvulsants, chemotherapeutic agents (including 
antibiotics and antineoplastic agents), analgesics, 
drugs of abuse, ethanol 
Metabolites/Electrolytes 
Phosphate, calcium, sodium, potassium, glucose, 
chloride, nitrate, uric acid, amino acids, lipids, 
carbohydrates 
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Tumour Markers 
CA 15-3, HER2/neu, CA 19-9, p53, leptin, CA 125, 
alpha fetoprotein, CEA, somatic mutations in tumor 
suppressor genes, loss of heterozygosity, promoter 
hypermethylation of genes, microsatellite DNA 
alterations 
 
Peri-implant sulcular fluid (PISF) 
The current criteria used in the diagnosis of periodontal conditions clinically, 
has created a limitation in the utility to predict disease progression in the 
future 
20
. The potential role of host response and microbial biomarkers 
obtained from oral fluids have been investigated and based on these 
investigations they are being used as complementary diagnostic tools for 
periodontal disease. Concentrations of host response molecules maybe used as 
a representation for a more accurate measurement of real-time disease activity 
than conventional clinical measurements 
28,37
  
Microbial communities from subgingival and supragingival biofilm have been 
clustered in complexes according by their relationship to commonly used 
clinical parameters 
83,105
. 
 
The red complex bacteria (Porphyromonas gingivalis, Tannerella forsythia, 
and Treponema denticola) and orange complex member (Prevotella 
intermedia) have been pointed out as the species responsible for chronic 
periodontitis 
37
, while Aggregatibacter actinomycetemcomitans for aggressive 
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periodontitis 
47
. Furthermore, besides being highly associated with disease, 
assessments of microbiological presence and load are able to predict its 
progression in susceptible sites 
9, 53
The pairing of both data has been proven 
valuable to increase their diagnostic abilities in crosssectional and longitudinal 
models in subjects afflicted with periodontitis
 36, 54
. Conversely, limited 
information regarding the usefulness of biomarkers upon peri-implantitis is 
available. 
Radiographic and clinical assessments such as radiographic bone loss 
evaluation, peri-implant probing, bleeding on probing (BOP), microbial 
testing, implant mobility, and suppuration all serve as traditional measuring 
tools for peri-implant surveillance and disease diagnosis 
86
. Moreover, an 
increasing interest for the assessment of numerous inflammatory mediators, 
host proteolytic enzymes and tissue breakdown biomarkers, in addition to 
angiogenic and matrix metalloproteinase inhibitors biomarkers within gingival 
crevicular fluid (GCF) and peri-implant crevicular fluid (PICF) has been 
targeted for disease detection and prediction to elucidate a broad overview of 
the different phases of the periodontal and peri-implant diseases 
87, 132 
Identifying a single predictive biomarker for periodontal and peri-implant 
diseases would be of great significance. However, microbial profiles and a 
combination of several host response biomarkers around dental implants could 
reveal a more precise assessment of a disease status than traditional clinical 
measurements as observed in a periodontitis model 
35, 36 
 
Factors that correlate with marginal bone loss in implants 
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A positive correlation has been found between oral hygiene and marginal bone 
loss around implants in the edentulous mandible 
48
. During peri-implant 
breakdown a complex microbiota is established, closely resembling that found 
in adult periodontitis 
31, 77
. When peri-implant tissue breakdown is induced by 
placing plaque retentive ligatures submarginally, a shift in the microflora 
occurs 
64, 65
. Apart from darkpigmented Gram-negative anaerobic rods, other 
bacterial species associated with per-implant infection include Bacteroides 
forsythus, Fusobacterium nucleatum, Camphylobacter, 
Peptostreptococcus micros, and Streptococcus intermedius 
58
. Organisms not 
primarily associated with periodontitis, such as Staphylococcus spp., Enterics 
and Candida spp. have also been found in peri-implant infection) 
87
. 
 
Association of peri-implant disease with periodontal disease 
Studies have shown that the microbiome that is found around implants that 
have failed are similar to that found around the teeth affected with 
periodontitis in their composition as well as their proportion of 
microorganisms 
100,116
. Hence, the association of peri-implant disease with 
periodontal disease have been reported for several studies. 
The incidence of the condition peri-implantitis has increased continuously 
over the last few years, ultimately relating it with the loss of implants. Many 
factors play a fundamental role in creating complications that are related to 
implant failures like the implant and prosthetic component's design as well as 
bacterial colonization around implants 
4
. The colonization of bacteria around 
dental implants can lead to some local diseases, the most common being: 
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mucositis and peri-implantitis. These two forms of infections resemble 
gingivitis and periodontitis respectively. 
Based on a study conducted by Renvert & Persson, showed that patients with 
a previous history of periodontitis have been proven to have an increased risk 
of acquiring peri-implant infections. Another study conducted by Heitz-
Mayfield & Lang 
64
, concluded that patients who are susceptible to 
periodontal disease, are seen to possess a higher susceptibility to peri-implant 
disease when compared to those patients without any history of periodontal 
disease. To decrease the chances of implant loss due to the presence of 
periodontopathogenic bacteria, several researchers have proposed the 
elimination of these pathogens before dental implant installation. 
Although, the microbiological profile at failing implants differs from those in 
peri-implant health, it is not known whether the host response observed in 
peri-implantitis patients is similar to that seen in periodontitis 
117
. 
Since a great number of patients receiving dental implants are patients with a 
history of periodontal disease, i.e. individuals who previously have shown a 
tissue destructive inflammatory response, a microbial challenge in conjunction 
with an aberrant host response are possible etiologic factors. 
Analysis of inflammatory mediators in crevicular fluid has also been used to 
compare peri-implant tissue health and disease. Neutrophil- derived enzymes 
such as neutral protease, neutrophil elastase, myeloperoxidase and b-
glucuronidase have been found in association with failing implant sites 
11
. 
Interleukin-1 (IL-1) is a potent proinflammatory cytokine that can influence 
the host response in the inflammatory tissue destruction. IL-1 is produced 
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mainly by macrophages but also by other cells including neurtrophilic 
granulocytes 
92
. 
Peri-implantitis may have a multifactorial background where an aberrant host 
response in conjunction with the bacterial challenge may contribute to the 
development of tissue destruction around implants. Elucidation of factors of 
importance for peri-implant tissue destruction should make it easier to predict 
which patient or implant is at risk for peri-implant complications during 
maintenance and retention of implants. In the present study, we therefore 
aimed to characterise markers of inflammation, microbiota and inflammatory 
host response at implants and teeth in patients with signs of marginal tissue 
destruction, i.e. peri-implantitis
 107,110
 
 
Salivary diagnostics and implant patients 
The current world of research is probing the different facets involved in 
periodontal disease diagnostics and is currently investigating the possible use 
of oral fluids, such as saliva, for disease assessment. The secretions obtained 
from the major salivary glands (parotid, submandibular and sublingual), which 
usually consist of a large number of proteins and peptides, are responsible for 
maintaining the integrity of the oral cavity
101, 121
. Also, because of its 
importance in oral biofilm formation and host defense, secreted saliva may 
play a significant role in the establishment and progression of periodontal 
disease. 
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Saliva an oral fluid is considered to be a mirror of the body. It could be used to 
monitor the general health and also the onset of specific diseases. Biomarkers, 
whether produced by normal healthy individuals or by individuals affected by 
specific systemic diseases, are tell-tale molecules that could be used to 
monitor health status, disease onset, treatment response and outcome. 
Informative biomarkers can further serve as early sentinels of disease, and this 
has been considered as the most promising alternative to classic environmental 
epidemiology
71, 130 
The salivary microbiota is a potential diagnostic indicator of several diseases. 
Culture-independent techniques are required to study the salivary microbial 
community since many of its members have not been cultivated. 
The study of the oral microbiota as well as its salivary component requires 
culture-independent techniques, since about one third of 700 bacterial species 
identified in the human oral cavity have not been cultivated . These may be 
based on PCR amplification and high-throughput sequencing of the bacterial 
16S rRNA genes (16S-HTS) or the metagenomic whole genome shotgun 
(WGS) sequencing 
39, 57
. The latter approach may include either the analysis of 
the totality of generated DNA fragments or of the 16S rRNA gene fragments 
retrieved from the metagenome (16S-WGS). Both 16S-WGS and 16S-HTS 
approach presents limitations and advantages over each other 
3, 84
. 
Salivary proteome: human salivary proteome project 
Human salivary proteome analysis is of importance, as it helps us understand 
oral health in general and the pathogenesis of a disease. Three research groups 
Review of Literature 
 
36 
 
were funded by the National Institute of Dental and Craniofacial Research / 
National Institutes of Health to decipher comprehensively the human salivary 
proteome. Significant progress has been made in cataloguing human saliva 
proteins and exploring their post-translational modifications 
78
. 
By using both two-dimensional gel electrophoresis / mass spectrometry and 
‗shotgun‘ proteomics approaches, we identified 309 distinct proteins in human 
whole saliva. In addition, after 3 years of collective identification and 
cataloguing of the salivary proteome by the three National Institute of Dental 
and Craniofacial Research-support salivary proteome projects, the first 
complete profile of the salivary secretory proteome has been completes. 
Collectively, 1166 salivary proteins have been identified: 914 from the parotid 
fluid and 917 from the combined submandibular and sublingual fluids 
30
. The 
University of California at Los Angeles is the data-centralization site, 
harbouring the entire database of the human salivary proteome known as the 
‗Salivary Proteome Knowledge Base‘ is a genome-wide view of the 
distribution of the parotid and combined submandibular and sublingual fluid 
proteomes 
44, 62
. 
Salivary transcriptome 
Based on earlier studies it was found that RNA molecules are elevated in the 
cases of oral cancer tissues and their levels in saliva are also high, which also 
prompted to the examination of the scope and complexity of RNA present in 
human saliva. High-density oligonucleotide microarrays (Affymetrix HG 
U133A) were used to profile salivary mRNA and revealed that there are 
~3,000 human mRNAs in the cell-free saliva supernatant of healthy subjects. 
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Of particular interest is that there is a normal saliva transcriptome core 
signature of 185 mRNAs that is present in all normal subjects, providing the 
rationale to use the salivary transcriptome for disease detection 
34, 80
. 
The presence of human mRNA in saliva may seem to be surprising. However, 
it was shown that endogenous mRNA is protected from immediate 
degradation in a similar manner as cell-free RNA in plasma. The utilization of 
cell-free RNA has been widely accepted. Two recent studies demonstrated that 
foetal cell-free RNA crossed the placenta and was detected in maternal serum. 
The first study involved the non-invasive determination of foetal aneuploidies 
from maternal plasma 
99
. The second study was a gene-expression microarray 
investigation of maternal and foetal whole blood that identified foetal mRNA 
markers in maternal blood that are independent of gender or polymorphism 
131
. 
Other research groups, particularly from forensic sciences, are focusing on 
multiplex mRNA profiling for the identification of body fluids, including 
saliva. Most recently a Dutch forensic group was able to perform a gene-
expression profile on saliva stains from crime scenes, leading to the 
identification of five saliva RNA markers (SPRR3, SPRR1A, KRT4, KRT6A 
and KRT13), stable for up to 180 days, which can be used for the 
identification of blood and saliva stains in forensic practice. Of importance is 
that these five saliva RNA markers selected for forensic applications are all in 
the normal saliva transcriptome core of 185 mRNAs, substantiating and 
independently validating our data. Lastly, Shaw and co-workers have 
identified a biomarker, amylase, which is highly correlated with sleep drive. 
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Importantly, both salivary amylase activity and mRNA levels are also 
responsive to extended waking in humans. These studies provide firm support 
for our work by showing that mRNA can be extracted from human saliva and 
used to develop standard tests 
46, 111
. 
Immunologic and enzymatic assays 
Enzyme-linked immunosorbent assay (ELISA) and 
Immunofluorescence techniques are basically antibody-based methods used to 
enumerate the specific species of microorganisms without actually cultivating 
the species. It is dependent on the specificity of developed antibodies to 
specific taxa. These techniques have the advantage that samples don‘t 
necessarily have to be cultured for their enumeration; they are rapid and less 
expensive than the method which involves a culture. However, they are 
limited to species for which reagents have been developed. It is difficult to use 
these techniques to evaluate species in large numbers of plaque samples and it 
is time-consuming to develop and validate specific antisera to new species 
61, 
134
.
 
DNA – DNA hybridization or checkerboard 
DNA-DNA hybridization is a molecular approach used to detect bacteria 
based on the hybridization of the target species to the ones that are the labelled 
genomic DNA that has been attached to nylon membranes. Based on extensive 
research and studies conducted by LoescheWJ et al, Haffajee 
83
Ximenez-
Fyvie LA, Feres M et al
118
 and Socransky 
104
  have reported that the levels of 
limited number of species with this method  is found in adult periodontitis, 
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periodontal health, refractory periodontitis and response to therapy. This 
method provides a major benefit for studies conducted on the oral microbial 
ecology due to advantages such as detection of multiple species from each 
sample simultaneously, and enabling the ease of study when it comes to a 
large sample size for large numbers of species 
136
. Checkerboard technique is a 
rapid, sensitive, and relatively inexpensive technique. It is also dependent on a 
culture technique to cultivate the target species for creating genomic probes. 
Like antibody-based assays, cross reactivity can be verified only with 
cultivated species hence specificity of the probe is an unknown variable. 
Polymerase chain reaction 
Kary Mullis first developed the technique of polymerase chain 
reaction (PCR) , which was used to amplify specific genes or parts of genes 
which are then used to identify bacterial species from which they had 
originally originated from 
61
. In a study conducted by Kumar PS et al (2005) 
24, 66
 species-specific PCR primers were designed and used in individual PCR 
reactions to detect prevalence of target species in plaque samples of healthy 
and diseased subjects. These studies confirmed that several species, including 
the ones that were uncultivated, were associated with oral health or 
periodontitis 
21, 89
. Given the appropriate primers, this method is of a rapid, 
simple nature, can detect small numbers of cells of a given species, and 
indicates the presence or absence of a species in the sample. It has certain 
disadvantages of not providing data, and it may not be cost effective for a 
larger sample size and for applications where relative levels of species are 
important, PCR may not be ideal.
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DNA Probes 
Oligonucleotide probes are short probes that are designed to identify 
unique regions of DNA within cells of a given bacterial species. These probes 
are highly specific and the likelihood of cross-reactions with other species is 
extremely low 
129
. Because they usually target a limited segment of DNA of an 
organism, oligonucleotide probes tend to be less sensitive for detection of low 
numbers of bacteria than whole genomic probes. 
Whole genomic DNA probes are constructed utilizing the entire 
genome of a bacterial species as the target and therefore can be quite sensitive. 
This in turn may increase the probability of cross-reactions between species 
because of common regions of DNA among closely related species 
45
. The 
technique can detect only species for which DNA probes have been prepared, 
creating a drawback as it cannot detect the novel pathogens or environmentally 
important species that might be detected in culture or by other molecular 
techniques. 
OPEN ENDED APPROACHES- 16S rRNA sequencing analysis: 
Open ended approaches usually allow identification of even 
uncultivated and previously unknown species. According to Spratt (2004) 
these approaches are based on the 16 S rRNA sequencing, it‘s amplification 
and resulting analysis of the 16S rRNA genes present within a microbiome 
sample. 16S rRNA has proven to be the most useful phylogenetic marker to 
identify bacteria and in turn determine their evolutionary relationships 
23, 102
. 
Ribosomal RNA gene is essential for life and present in all prokaryotes. It 
contains nucleic acid sequences with variable and highly conserved regions; 
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these conserved regions are used to design universal PCR primers which are 
capable of recognizing segments of 16S rRNA gene sequence of all bacterial 
species and hypervariable regions are used as signatures to discriminate one 
species from another. 16S rRNA gene is large enough (about 1500 bases) to 
provide sufficient sequence variability among bacteria, thereby making 
comparisons possible at different taxonomic levels 
39
. 
DNA and protein sequencing started in the 1970s when the virus 
Lambda (50,000 nucleotides) was sequenced by Sanger et al. Frederick 
Sanger and colleagues. They described the use of chain-terminating 
dideoxynucleotide analogues that caused base-specific termination of primed 
DNA synthesis and this came to be popularly known as Sanger sequencing 
method. This method of sequencing was then considered to be of gold 
standard, and over the years, whole genome sequencing of many bacteria has 
been carried out using this method. Sanger technology was used in the 
sequencing of the first human genome, which was completed in 2003 through 
the Human Genome Project, a 13-year effort with an estimated cost of 2.7 
billion dollars 
74
 
Over the past decade, next generation sequencing technologies have 
emerged, which are high throughput and they are able to generate three to four 
orders of magnitude more sequences and are also relatively less expensive.
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NEXT GENERATION SEQUENCING TECHNOLOGY (NGS): 
Next generation sequencing method employs a wide spectrum of 
technologies such as: sequencing by ligation, sequencing by synthesis, single 
molecule DNA sequencing and colony sequencing. NGS is performed by 
repeated cycles of polymerase-mediated nucleotide extensions or by 
machinery automated cyclical ligation of oligonucleotides 
7
.
 
 
 
Fundamentals of NGS platforms: 
NGS platforms share a common technological feature—massive 
parallel sequencing of clonally amplified or single DNA molecules that are 
spatially separated in a flow cell
7, 115
. This design is a paradigm shift from that 
of Sanger sequencing, which is based on electrophoretic separation of chain-
termination products produced in individual sequencing reactions. In NGS, 
sequencing is performed by repeated cycles of polymerase-mediated 
nucleotide extensions or, in one format, by iterative cycles of oligonucleotide 
ligation. As a massively parallel process, NGS generates hundreds of 
megabases to gigabases of nucleotide sequence output in a single instrument 
run, depending on the platform. The 2 basic procedures are ligation of DNA 
fragments with oligonucleotide adaptors and fragment immobilization to a 
solid surface, such as a bead 
65, 88
. 
The three commonly used platforms for massive parallel DNA 
sequencing at present are the Roche/454 FLX, the Illumina/ Solexa Genome 
Analyze 
34,75 
 and the Applied Biosystems ⁄ SOLiD (Life Technologies, 
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Carlsbad, CA). The most recent powerful NGS platforms have significant 
reductions in the run time and remarkable data output, they include HiSeq and 
the Ion Torrent Personal Genome Machine (PGM). 
           Until recently, the main focus in dental research has been focused on 
studying a small fraction of the oral microbiome which mainly consisted of 
opportunistic pathogens. After the advent of next-generation sequencing 
(NGS) technologies, researchers now have the tools that allow for profiling of 
the microbiomes and metagenomes at  never before thought of depths thereby, 
creating a massive opportunity to understand the oral microbiome as a whole, 
better 
91
. The major advantages of NGS are the high throughput and the fact 
that there is no need to target specific taxa. The availability of sequencing 
facilities and the relatively low cost have contributed to an exponential growth  
of NGS datasets. Using this technology we have conducted this study, to 
identify the microbiome associated with implant patients thereby establishing 
a sound knowledge as to the key colonisers which can further help us identify 
and rectify any future implant related diseases . 
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FIGURE 1: BACTERIAL COMPLEXES 
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FIGURE 2: ROCHE 454 LIFE SCIENCES SYSTEM 
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FIGURE 3: ILLUMINA SOLEXA GENOME ANALYZER 
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MATERIALS AND METHODS 
Study population 
Individuals seeking dental treatment in Ragas Dental College and 
Hospital, Chennai were used in the present study. Certificate of Ethical 
clearance for the study was obtained from the Institutional Review Board of 
Ragas Dental College. Twenty patients fitting the aim of the study visiting the 
dental out-patient facility 
Saliva samples were obtained from the patients after obtaining their 
consent. Twenty patients fitting the aim of the study visiting the dental out-
patient facility were included in the study. They were split into two groups of 
ten each. The first group consisted of periodontally healthy individuals and 
was designated as Group H (Control Group). The second group consisted of 
individuals who had endosseous implants placed in their oral cavity 6 months 
post loading of the prosthesis and they were designated as Group I (Test 
Group).  
The American Academy of Periodontology (AAP) has defined periodontal 
health as “The condition of a patient when there is function without evidence 
of disease or abnormality” 4. 
The diagnostic definition of peri-implant health is based on the following 
criteria: 1) absence of peri-implant signs of soft tissue inflammation (redness, 
swelling, profuse bleeding on probing), and 2) the absence of further 
additional bone loss following initial healing 
72
. 
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In general, however, the probing depth associated with peri‐implant health 
should be ≤5.0 mm109. 
Control group comprised of ten subjects with clinically non-inflammed, 
healthy gingiva having probing pocket depth of (PPD) lesser than or equal to 
3mm, with no signs of clinical attachment loss (CAL) and no bleeding on 
Probing (BOP). 
Test group comprised of ten subjects with endosseous implants placed in their 
oral cavity 6 months post loading of prosthesis, and the clinical signs taken 
into consideration were healthy peri-implant gingiva having probing pocket 
depth of (PPD) lesser than or equal to 4mm, with no signs of clinical 
attachment loss (CAL) and no bleeding on Probing (BOP). 
 
 INCLUSION CRITERIA  
 Subjects included in this study were expected to exhibit good general 
health 
 Subjects should have met the criteria of periodontal health as described 
above 
EXCLUSION CRITERIA  
 Patient with systemic disorders, such as diabetes mellitus or 
immunological disorders, HIV. 
 Patients on drugs that have potential to interfere with the study such as 
immunosuppressant drugs or steroids. 
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 Patients with history of tobacco usage. 
 Patients under antimicrobial therapy for the past 6 months 
 
SALIVA SAMPLE COLLECTION:- 
 Unstimulated whole saliva was collected in sterile salivary sample tubs 
in the morning and subjects refrained from eating, drinking, smoking 
or performing any oral hygiene for at least 2 hours prior to the 
collection following Navazesh method of saliva collection.  
 Participants were instructed not to consume food or beverages an hour 
before the sample collection. 
 The patients were asked to rinse their mouth and wait at least 10 
minutes before providing a specimen 
 Clear and comprehensible labeling of containers was done. (‘H’ for 
healthy samples and ‘I’ for implant samples, each healthy and implant 
sample designated with a number for keeping count of the patient 
samples that were collected) 
 Samples were frozen and stored at -80°C until the sample collection 
period is completed. 
 Salivary Samples were sent for Next Generation Sequencing for 
microbiome analysis to a laboratory after being packaged in containers 
with geo packs to maintain the temperature 
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PCR KIT CONTENTS 
 10mM Tris pH 8.5 
 AMPure XP beads 
 Freshly Prepared 80% Ethanol (EtOH) 
 96-well 0.2 ml PCR plate 
 Microseal „B‟ seal 
 96-well MIDI plate 
 
PROCEDURE 
DNA extraction, 16S rRNA amplification, library construction and 
sequencing 
 Genomic DNA was extracted from the ten saliva samples obtained 
from patients with dental implants placed in their oral cavity 6 months post 
loading with the Fast DNA kit and the FastPrep24-5G instrument according to 
manufacturer‟s recommendations (MP Biomedicals, Santa Ana, CA). 
Extracted DNA was then purified with silica-based spin filters (FastDNA kit) 
and the DNA was amplified using the 16S V3 (341F) forward and V4 (805R) 
reverse primer pairs with added Illumina adapter overhang nucleotide 
sequences.  
The amplicon generation was done using PCR to amplify a template 
out of a DNA sample using the region-of-interest specific primers with 
overhang adapters attached. Amplicon synthesis was then performed using 
thermocycling with 2.5μl of microbial  DNA (5ng/ μl), 5μl of amplicon PCR 
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forward primer (1μM), 5μl of amplicon PCR reverse primer (1μM), and 12.5μl 
of 2x KAPA HiFi HotStart Ready Mix (Kapa Biosystems) at 95°C. Initial 
denaturation for 3 minutes, followed by 25 cycles of 95°C for 30 seconds, 
55°C for 30 seconds, and 72°C for 30 seconds, and a final extension at 72°C 
for 5 minutes. 
Reactions were cleaned up with Agencourt AMPure XP beads 
(Beckman Coulter Genomics) according to the protocol specified by the 
manufacturer. Attachment of dual indices and Illumina sequencing adapters 
was performed using 5μl of amplicon PCR product DNA, 5μl of Illumina 
Nextera XT Index 1 Primer  (N7xx) from the Nextera XT Index kit, 5 μl of 
Nextera XT Index 2 Primer (S5xx), 25 μl of 2x KAPA HiFi HotStart Ready 
Mix, and 10μl of PCR-grade water (UltraClean DNA-free PCR water; MO 
BIO Laboratories, Inc., Carlsbad, CA, USA), with thermocycling at 95°C for 3 
minutes, followed by 8 cycles of 95°C for 30 seconds, 55°C for 30 seconds, 
and 72 °C for 30 seconds, and a final extension at 72 °C for 5 minutes. 
Constructed 16S metagenomic libraries were then purified with 
Agencourt AMPure XP beads and quantified using a fluorometric 
quantification method that uses dsDNA binding dyes with Quant-iT PicoGreen 
and the KAPA Library Quantification Kit (KAPABIOSYSTEMS). Library 
quality control was performed using the Agilent Technologies 2100 
Bioanalyzer to ascertain the quality and average size distribution. 
Samples were denatured and diluted to a final concentration of 10 pM 
with a 20 % PhiX (Illumina) control. Sequencing was performed using the 
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Illumina Miseq System. After samples are loaded, the MiSeq system provides 
on instrument secondary analysis using the MiSeq Reporter software (MSR). 
All eight samples were multiplexed and sequenced in a single lane on the 
MiSeq using 2 × 300 bp paired-end sequencing. Operational taxonomic units 
(OTUs) were assigned to each sequence using Human Oral Microbiome 
Database. The Metagenomics workflow classified organisms from the V3 and 
V4 amplicon using a database of 16S rRNA data, and this classification is 
based on the Greengenes database. The output of this workflow is a 
classification of reads at various taxonomic levels: kingdom, phylum, class, 
order, family, genus, and species. The analysis output is represented using Bar 
Graphs, Tables and Cluster Pie Charts. 
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Statistical analysis 
Data was analyzed as recommended by studies conducted previously. 
Data obtained was compiled systematically using the excel spreadsheet 
provided by Microsoft Office, the dataset was then subdivided and distributed 
meaningfully and presented as graphs and tables. 
Statistical analysis was performed using the Statistical Package of 
Social Sciences software (IBM Corp. Released 2011. SPSS Statistics for 
Windows, version 20.0 Armonk, NY: IBM Corp). Normality test was done 
using Kolmogorov-Smirnov test and Shapiro-Wilk numerical test, and it was 
observed that all the variables were normally distributed. Depending on the 
nature of the data, appropriate parametric statistical tests were chosen. P value 
of <0.05 was considered to be significant. 
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IMAGE 1: HEALTHY PERIODONTIUM 
 
 
IMAGE 2: IMPLANT PLACEMENT AND POST LOADING 
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IMAGE 3: STERILE SALIVARY TUB 
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IMAGE 5: 4 BASIC STEPS IN ILLUMINA NGS WORK FLOW 
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IMAGE 6: PARTIAL END SEQUENCING AND ALIGNMENT 
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RESULTS 
 The present study was carried out among a population of twenty 
individuals seeking dental treatment in Ragas Dental College and Hospital, 
Chennai. The age of the patients were categorized to be greater than 30 years 
years with a mean age of 35.4 years. 
Unstimulated saliva samples were collected using sterile containers 
from ten periodontally healthy control individuals (designated as H1, H2, H3 
…H10) and from implant patients six months post loading (designated as I1, 
I2, I3…I10). 
Amplicons from V3-V4 hypervariable regions of 16S rRNA gene 
underwent sequencing. The results obtained from the sequencing process are 
represented according to taxonomic classification system of bacteria, and the 
individual comparisons are depicted via tables and graphs. 
Distribution of bacteria in healthy and implant sites: 
The distribution of bacteria in the healthy and implant sites based on 
phylum level, genus and species are depicted in Table 1 and Graph 1-A, 1-B 
and 1-C. In the healthy sites, a total of 10 phyla, 53 genera and 187 species; 
and in implant sites 11 phyla, 60 genera and 228 species have been identified.  
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Top 5 phyla in healthy and implant sites:  
The top 5 phyla in healthy and implant sites along with their respective 
abundances are depicted in Table 2 and Graph 2-A and 2-B. In healthy sites, 
phylum Firmicutes has shown highest abundance of 28.63% followed by 
Bacteroidetes (28.43%), Fusobacteria (15.9%), Proteobacteria (13.32%) and 
Actinobacter (6.56%). In implant sites, phylum Firmicutes (31.7%) has shown 
the highest abundance of 31.7% followed by Bacteroidetes (26.1%), 
Fusobacteria (15.49%), Proteobacteria (9.23 %) and TM7 (7.33%). The 
phylum not present in healthy samples that was present in implant 
patients was found to be Synergistetes. 
 
Top 5 genera in healthy and implant sites:  
The top 5 genera in healthy and implant sites along with their respective 
abundances have been depicted in Table 3 and Graph 3-A and 3-B. In both 
healthy and implant sites, Prevotella is the most abundant genus to be 
identified with an abundance of 12.82% and 12.4% respectively. Following 
this is Leptotrichia with values of 9.14% and 9.23% respectively, the next four 
genera in healthy sites are Fusobacterium (6.75%), Veillonella (6.26%), 
Porphyromonas (5.16%) and Nisseria (4.97%) and in implant sites are 
Saccharibacteria (6.61%), Fusobacterium (6.15%), Porphyromonas (5.52%) 
and Veillonella (5.52%). The genera found in healthy patients that were 
not present in implant patients are: Adlercreutzia, Anaerococcus, 
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Bergeyella, Clostridiales, Johnsonella, Odoribacter, Johnsonella, 
Pyramidobacter, Scardovia, Sporanaerobacter. The genera found in patient 
with implants that were not present in healthy patients are: 
Absconditabacteria, Anaerovorax, Eggerthella, Erwinia, Novosphingobium, 
Slackia 
Species present in healthy samples that are not present in implant 
samples: 
 Acinetobacter johnsonii  
 Actinomyces sp. HMT 175  
 Aggregatibacter paraphrophilus  
 Aggregatibacter sp. HMT 513  
 Bifidobacterium animalis  
 Capnocytophaga sp. HMT 878  
 Eggerthella lenta  
 Enterobacter cancerogenus  
 Enterococcus casseliflavus  
 Enterococcus saccharolyticus  
 Filifactor alocis  
 Gemella bergeri  
 Haemophilus influenzae  
 Kingella sp. HMT 932  
 Klebsiella aerogenes  
 Lactobacillus crispatus  
 Novosphingobium panipatense  
 Peptostreptococcaceae [XI][G-5] bacterium 
HMT 493  
 Prevotella sp. HMT 304  
 Slackia exigua  
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Species present in implant samples that are not present in healthy 
samples: 
 Actinomyces oris  
 Actinomyces sp. HMT 169  
 Anaerococcus octavius  
 Bacteroides heparinolyticus  
 Bacteroidetes [G-3] bacterium HMT 280  
 Bacteroidetes [G-3] bacterium HMT 436  
 Bacteroidetes [G-5] bacterium HMT 505  
 Bacteroidetes [G-6] bacterium HMT 516  
 Bulleidia extructa  
 Butyrivibrio sp. HMT 080  
 Capnocytophaga sp. HMT 324  
 Capnocytophaga sp. HMT 338  
 Clostridiales [F-1][G-1] bacterium HMT 093  
 Dialister pneumosintes  
 Enterococcus faecalis  
 Fretibacterium fastidiosum  
 Fretibacterium sp. HMT 360  
 Gracilibacteria (GN02) [G-1] bacterium HMT 871  
 Johnsonella sp. HMT 166  
 Lactobacillus fermentum  
 Lactobacillus gasseri  
 Lactobacillus salivarius  
 Leptotrichia sp. HMT 879  
 Neisseria sp. HMT 018  
 Oribacterium sp. HMT 102  
 Peptoniphilaceae [G-2] bacterium HMT 790  
 Peptostreptococcaceae [XI][G-1] infirmum  
 Peptostreptococcaceae [XI][G-4] bacterium HMT 369  
 Peptostreptococcaceae [XI][G-5] saphenum  
 Peptostreptococcaceae [XI][G-6] minutum  
 Peptostreptococcaceae [XI][G-6] nodatum  
 Peptostreptococcaceae [XI][G-7] bacterium HMT 081  
 Prevotella dentalis  
 Prevotella enoeca  
 Prevotella multiformis  
 Prevotella multisaccharivorax  
 Prevotella sp. HMT 526  
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 Pseudopropionibacterium propionicum  
 Pyramidobacter piscolens  
 Saccharibacteria (TM7) [G-1] bacterium HMT 488  
 Scardovia wiggsiae  
 Selenomonas artemidis  
 Selenomonas dianae  
 Selenomonas sp. HMT 126  
 Selenomonas sp. HMT 133  
 Selenomonas sp. HMT 137  
 Selenomonas sp. HMT 146  
 Selenomonas sp. HMT 149  
 Selenomonas sp. HMT 388  
 Selenomonas sp. HMT 442  
 Selenomonas sp. HMT 479  
 Stomatobaculum sp. HMT 097  
 Streptococcus sobrinus  
 Treponema amylovorum  
 Treponema parvum  
 Treponema sp. HMT 230  
 Treponema sp. HMT 231  
 Treponema sp. HMT 238  
 Treponema sp. HMT 249  
 Treponema sp. HMT 258  
 Treponema sp. HMT 517  
 Treponema vincentii  
 Veillonella sp. HMT 917  
 Veillonellaceae [G-1] bacterium HMT 135  
 Veillonellaceae [G-1] bacterium HMT 145  
 Veillonellaceae [G-1] bacterium HMT 483 
 
Comparison of subgingival microbiome in healthy versus gingival 
recession sites at genus level: phylogenetic tree 
The subgingival microbiome was compared between healthy and 
gingival recession sites at genus level and is represented in the form of a 
circular phylogenetic tree in Graph 3-C. The tree has been constructed with 
phyloT software and is displayed using iTOL (Letunic and Bork, 2011). The 
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bars on the outer band (maroon), represents the abundance of bacterial genera 
in healthy (green) and implant sites (blue) sites. 
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TABLE 1: DISTRIBUTION OF BACTERIA IN HEALTHY AND 
IMPLANT 
CRITERIA PHYLUM GENUS SPECIES 
HEALTH 10 53 187 
IMPLANT 11 60 228 
 
TABLE 2: TOP 5 PHYLA IN HEALTH AND IMPLANT 
S.No HEALTH ABUNDANCE 
(%) 
IMPLANT ABUNDANCE 
(%)  
1 Firmicutes 28.62823 Firmicutes 31.7029 
2 
Bacteroidetes 28.42942 Bacteroidetes 26.08696 
3 
Fusobacteria 15.90457 Fusobacteria 15.48913 
4 
Proteobacteria 13.32008 Proteobacteria 9.23913 
5 
Actinobacteria 6.560636 TM7 7.336957 
 
TABLE 3: TOP 20 GENERA IN HEALTH AND IMPLANT 
S.No HEALTH ABUNDANCE 
(%) 
IMPLANT ABUNDANCE 
(%)  
1 Prevotella 12.82306 Prevotella 12.40942 
2 
Leptotrichia 9.145129 Leptotrichia 9.32971 
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3 
Fusobacterium 6.759443 Saccharibacteria 6.612319 
4 
Veillonella 6.262425 Fusobacterium 6.15942 
5 
Porphyromonas 5.168986 Porphyromonas 5.525362 
6 
Neisseria 4.970179 Veillonella 5.525362 
7 
Streptococcus 4.970179 Streptococcus 5.344203 
8 
Saccharibacteria 4.771372 Capnocytophaga 4.891304 
9 
Capnocytophaga 4.572565 Selenomonas 2.717391 
10 
[Prevotella] 3.777336 Oribacterium 2.626812 
11 
Gemella 2.982107 Gemella 2.536232 
12 
Oribacterium 2.584493 Neisseria 2.445652 
13 
Rothia 2.485089 Treponema 1.992754 
14 
Haemophilus 2.286282 Haemophilus 1.902174 
15 
Bifidobacterium 2.186879 Campylobacter 1.811594 
16 
Campylobacter 2.087475 Rothia 1.630435 
17 Granulicatella 1.789264 
Absconditabacteri
a 
1.630435 
18 
Absconditabacteria 1.39165 Bifidobacterium 1.539855 
19 
Actinobacillus 1.39165 Ruminococcus 1.539855 
20 
Ruminococcaceae 1.39165 Granulicatella 1.358696 
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TABLE 4: TOP 20 SPECIES IN HEALTH AND IMPLANT 
 
S.No IMPLANT ABUNDANCE 
(%) 
HEALTH ABUNDANCE 
(%)  
1 Uncultered 3.26087 
Porphyromonas 
pasteri 
2.683897 
2 
Porphyromonas 
pasteri 
2.807971 Uncultured 2.683897 
3 
Fusobacterium 
nucleatum subsp. 
vincentii 
1.992754 
Fusobacterium 
nucleatum subsp. 
vincentii 
2.186879 
4 
Capnocytophaga 
sputigena 
1.358696 
Veillonella 
parvula 
1.590457 
5 Veillonella parvula 1.358696 
Capnocytophaga 
sputigena 
1.491054 
6 
Capnocytophaga 
leadbetteri 
1.177536 
Alloprevotella sp. 
HMT 473 
1.192843 
7 
Capnocytophaga 
granulosa 
1.086957 
Prevotella 
veroralis 
1.192843 
8 
Megasphaera 
micronuciformis 
0.996377 
Fusobacterium 
periodonticum 
1.093439 
9 Catonella morbi 0.905797 
Bergeyella sp. 
HMT 322 
0.994036 
10 
Fusobacterium 
periodonticum 
0.905797 
Campylobacter 
concisus 
0.994036 
11 
Gemella 
morbillorum 
0.905797 
Fusobacterium sp. 
HMT 370 
0.994036 
12 
Granulicatella 
adiacens 
0.905797 
Gemella 
haemolysans 
0.994036 
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13 
Haemophilus 
parainfluenzae 
0.905797 
Gemella 
morbillorum 
0.994036 
14 
Leptotrichia 
hofstadii 
0.905797 
Gemella 
sanguinis 
0.994036 
15 
Oribacterium 
parvum 
0.905797 
Granulicatella 
adiacens 
0.994036 
16 
Prevotella sp. 
HMT 313 
0.905797 
Haemophilus 
parainfluenzae 
0.994036 
17 
Prevotella 
veroralis 
0.905797 Neisseria flava 0.994036 
18 
Saccharibacteria 
(TM7) [G-1] 
bacterium HMT 
352 
0.905797 
Oribacterium 
parvum 
0.994036 
19 
Saccharibacteria 
(TM7) [G-3] 
bacterium HMT 
351 
0.905797 
Oribacterium 
sinus 
0.994036 
20 
Saccharibacteria 
(TM7) [G-6] 
bacterium HMT 
870 
0.905797 
Prevotella 
melaninogenica 
0.994036 
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TABLE 5: PERIODONTAL HEALTH-ASSOCIATED MICROBIOME 
(187 species- present in health, not in implant) 
 
A 93 Neisseria flava 
1 Abiotrophia defectiva 94 Neisseria flavescens 
2 
Absconditabacteria (SR1) [G-1] bacterium 
HMT 345 
95 Neisseria oralis 
3 
Absconditabacteria (SR1) [G-1] bacterium 
HMT 874 
96 Neisseria perflava 
4 
Absconditabacteria (SR1) [G-1] bacterium 
HMT 875 
97 Neisseria polysaccharea 
5 Actinomyces graevenitzii 98 Neisseria subflava 
6 Actinomyces sp. HMT 172 
 
O 
7 Actinomyces sp. HMT 180 99 Oribacterium asaccharolyticum 
8 Aggregatibacter aphrophilus 100 Oribacterium parvum 
9 Aggregatibacter paraphrophilus 101 Oribacterium sinus 
10 Aggregatibacter segnis 
 
P 
11 Aggregatibacter sp. HMT 458 102 Parvimonas micra 
12 Alloprevotella rava 103 Parvimonas sp. HMT 393 
13 Alloprevotella sp. HMT 308 104 Peptostreptococcaceae [XI][G-1] sulci 
14 Alloprevotella sp. HMT 473 105 
Peptostreptococcaceae [XI][G-5] bacterium 
HMT 493 
15 Alloprevotella sp. HMT 914 106 
Peptostreptococcaceae [XI][G-7] bacterium 
HMT 922 
16 Alloprevotella tannerae 107 
Peptostreptococcaceae [XI][G-7] yurii 
subspp. yurii & margaretiae 
17 Atopobium parvulum 108 Peptostreptococcaceae [XI][G-9] brachy 
18 Atopobium rimae 109 Peptostreptococcus stomatis 
 
B 110 Porphyromonas catoniae 
19 Bacteroidales [G-2] bacterium HMT 274 111 Porphyromonas endodontalis 
20 Bergeyella sp. HMT 206 112 Porphyromonas gingivalis 
21 Bergeyella sp. HMT 322 113 Porphyromonas pasteri 
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22 Bifidobacterium breve 114 Porphyromonas sp. HMT 275 
23 Bifidobacterium dentium 115 Porphyromonas sp. HMT 277 
24 Bifidobacterium longum 116 Porphyromonas sp. HMT 278 
25 Bifidobacterium scardovii 117 Porphyromonas sp. HMT 284 
 
C 118 Porphyromonas sp. HMT 285 
26 Campylobacter concisus 119 Porphyromonas sp. HMT 930 
27 Campylobacter gracilis 120 Prevotella aurantiaca 
28 Campylobacter rectus 121 Prevotella denticola 
29 Campylobacter sp. HMT 044 122 Prevotella histicola 
30 Capnocytophaga granulosa 123 Prevotella loescheii 
31 Capnocytophaga leadbetteri 124 Prevotella maculosa 
32 Capnocytophaga sp. HMT 326 125 Prevotella melaninogenica 
33 Capnocytophaga sp. HMT 332 126 Prevotella micans 
34 Capnocytophaga sp. HMT 335 127 Prevotella nanceiensis 
35 Capnocytophaga sp. HMT 336 128 Prevotella nigrescens 
36 Capnocytophaga sputigena 129 Prevotella oralis 
37 Cardiobacterium hominis 130 Prevotella oris 
38 Catonella morbi 131 Prevotella oulorum 
39 Corynebacterium durum 132 Prevotella pallens 
 
D 133 Prevotella pleuritidis 
40 Dialister invisus 134 Prevotella salivae 
 
E 135 Prevotella scopos 
41 Eggerthella lenta 136 Prevotella shahii 
42 Enterococcus durans 137 Prevotella sp. HMT 305 
43 Enterococcus italicus 138 Prevotella sp. HMT 306 
44 Escherichia coli 139 Prevotella sp. HMT 309 
 
F 140 Prevotella sp. HMT 313 
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45 Finegoldia magna 141 Prevotella sp. HMT 314 
46 Fusobacterium naviforme 142 Prevotella sp. HMT 317 
47 Fusobacterium nucleatum subsp. animalis 143 Prevotella sp. HMT 443 
48 
Fusobacterium nucleatum subsp. 
polymorphum 
144 Prevotella sp. HMT 472 
49 Fusobacterium nucleatum subsp. vincentii 145 Prevotella sp. HMT 475 
50 Fusobacterium periodonticum 146 Prevotella veroralis 
51 Fusobacterium sp. HMT 203 
 
R 
52 Fusobacterium sp. HMT 370 147 Rothia aeria 
 
G 148 Rothia dentocariosa 
53 Gemella haemolysans 149 Rothia mucilaginosa 
54 Gemella morbillorum 150 
Ruminococcaceae [G-1] bacterium HMT 
075 
55 Gemella sanguinis 151 
Ruminococcaceae [G-2] bacterium HMT 
085 
56 
Gracilibacteria (GN02) [G-2] bacterium 
HMT 873  
S 
57 Granulicatella adiacens 152 
Saccharibacteria (TM7) [G-1] bacterium 
HMT 346 
58 Granulicatella elegans 153 
Saccharibacteria (TM7) [G-1] bacterium 
HMT 347 
 
H 154 
Saccharibacteria (TM7) [G-1] bacterium 
HMT 348 
59 Haemophilus haemolyticus 155 
Saccharibacteria (TM7) [G-1] bacterium 
HMT 349 
60 Haemophilus parainfluenzae 156 
Saccharibacteria (TM7) [G-1] bacterium 
HMT 352 
61 Haemophilus paraphrohaemolyticus 157 
Saccharibacteria (TM7) [G-1] bacterium 
HMT 869 
62 Haemophilus pittmaniae 158 
Saccharibacteria (TM7) [G-2] bacterium 
HMT 350 
63 Haemophilus sp. HMT 036 159 
Saccharibacteria (TM7) [G-3] bacterium 
HMT 351 
64 Haemophilus sp. HMT 908 160 
Saccharibacteria (TM7) [G-5] bacterium 
HMT 356 
65 Haemophilus sputorum 161 
Saccharibacteria (TM7) [G-6] bacterium 
HMT 870 
 
K 162 Selenomonas noxia 
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66 Kingella oralis 163 Selenomonas sp. HMT 136 
67 Klebsiella pneumoniae 164 Shuttleworthia satelles 
 
L 165 Solobacterium moorei 
68 Lachnoanaerobaculum orale 166 Stomatobaculum longum 
69 Lachnoanaerobaculum umeaense 167 Stomatobaculum sp. HMT 097 
70 Lautropia mirabilis 168 Streptococcus lactarius 
71 Leptotrichia buccalis 169 Streptococcus mitis 
72 Leptotrichia goodfellowii 170 
Streptococcus oralis subsp. dentisani clade 
058 
73 Leptotrichia hofstadii 171 Streptococcus parasanguinis clade 411 
74 Leptotrichia hongkongensis 172 Streptococcus peroris 
75 Leptotrichia shahii 173 Streptococcus pneumoniae 
76 Leptotrichia sp. HMT 212 174 Streptococcus salivarius 
77 Leptotrichia sp. HMT 215 175 Streptococcus sanguinis 
78 Leptotrichia sp. HMT 217 176 Streptococcus thermophilus 
79 Leptotrichia sp. HMT 218 
 
T 
80 Leptotrichia sp. HMT 221 177 Tannerella forsythia 
81 Leptotrichia sp. HMT 225 178 Tannerella sp. HMT 286 
82 Leptotrichia sp. HMT 392 179 Tannerella sp. HMT 808 
83 Leptotrichia sp. HMT 417 180 Treponema socranskii 
84 Leptotrichia sp. HMT 463 
 
U 
85 Leptotrichia sp. HMT 498 181 Uncultured 
86 Leptotrichia sp. HMT 847 
 
V 
87 Leptotrichia wadei 182 Veillonella atypica 
 
M 183 Veillonella denticariosi 
88 Megasphaera micronuciformis 184 Veillonella dispar 
89 Mycoplasma orale 185 Veillonella parvula 
90 Mycoplasma salivarium 186 Veillonella rogosae 
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N 187 Veillonella sp. HMT 780 
91 Neisseria cinerea 
  
92 Neisseria elongata 
  
 
TABLE 6: IMPLANT ASSOCIATED MICROBIOME (228 species) 
 
A 115  Oribacterium parvum  
1  Abiotrophia defectiva  116  Oribacterium sinus  
2 
 Absconditabacteria (SR1) [G-1] bacterium 
HMT 345  
117  Oribacterium sp. HMT 078  
3 
 Absconditabacteria (SR1) [G-1] bacterium 
HMT 874   
P 
4 
 Absconditabacteria (SR1) [G-1] bacterium 
HMT 875  
118  Parvimonas micra  
5  Actinomyces graevenitzii  119  Parvimonas sp. HMT 393  
6  Actinomyces sp. HMT 180  120  Peptostreptococcaceae [XI][G-1] sulci  
7  Aggregatibacter segnis  121 
 Peptostreptococcaceae [XI][G-7] 
bacterium HMT 081  
8  Aggregatibacter sp. HMT 458  122 
 Peptostreptococcaceae [XI][G-9] 
brachy  
9  Aggregatibacter sp. HMT 949  123  Peptostreptococcus stomatis  
10  Alloprevotella rava  124  Porphyromonas catoniae  
11  Alloprevotella sp. HMT 308  125  Porphyromonas endodontalis  
12  Alloprevotella sp. HMT 473  126  Porphyromonas gingivalis  
13  Alloprevotella tannerae  127  Porphyromonas pasteri  
14  Anaeroglobus geminatus  128  Porphyromonas sp. HMT 275  
15  Atopobium parvulum  129  Porphyromonas sp. HMT 277  
16  Atopobium rimae  130  Porphyromonas sp. HMT 278  
 
B 131  Porphyromonas sp. HMT 284  
17  Bacteroidaceae [G-1] bacterium HMT 272  132  Porphyromonas sp. HMT 285  
18  Bacteroidales [G-2] bacterium HMT 274  133  Porphyromonas sp. HMT 930  
19  Bacteroides heparinolyticus  134  Prevotella aurantiaca  
20  Bacteroidetes [G-3] bacterium HMT 280  135  Prevotella baroniae  
21  Bacteroidetes [G-3] bacterium HMT 436  136  Prevotella buccae  
22  Bacteroidetes [G-5] bacterium HMT 511  137  Prevotella denticola  
23  Bacteroidetes [G-6] bacterium HMT 516  138  Prevotella histicola  
24  Bergeyella sp. HMT 206  139  Prevotella intermedia  
25  Bergeyella sp. HMT 322  140  Prevotella loescheii  
26  Bifidobacterium breve  141  Prevotella melaninogenica  
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27  Bifidobacterium dentium  142  Prevotella nanceiensis  
28  Bifidobacterium longum  143  Prevotella nigrescens  
29  Bifidobacterium scardovii  144  Prevotella oris  
30  Butyrivibrio sp. HMT 080  145  Prevotella oulorum  
31  Butyrivibrio sp. HMT 455  146  Prevotella pallens  
 
C 147  Prevotella pleuritidis  
32  Campylobacter concisus  148  Prevotella saccharolytica  
33  Campylobacter gracilis  149  Prevotella salivae  
34  Campylobacter rectus  150  Prevotella scopos  
35  Campylobacter sp. HMT 044  151  Prevotella shahii  
36  Capnocytophaga granulosa  152  Prevotella sp. HMT 300  
37  Capnocytophaga leadbetteri  153  Prevotella sp. HMT 301  
38  Capnocytophaga sp. HMT 323  154  Prevotella sp. HMT 306  
39  Capnocytophaga sp. HMT 326  155  Prevotella sp. HMT 309  
40  Capnocytophaga sp. HMT 332  156  Prevotella sp. HMT 313  
41  Capnocytophaga sp. HMT 336  157  Prevotella sp. HMT 314  
42  Capnocytophaga sp. HMT 412  158  Prevotella sp. HMT 317  
43  Capnocytophaga sp. HMT 863  159  Prevotella sp. HMT 443  
44  Capnocytophaga sp. HMT 864  160  Prevotella sp. HMT 472  
45  Capnocytophaga sputigena  161  Prevotella sp. HMT 526  
46  Cardiobacterium hominis  162  Prevotella veroralis  
47  Catonella morbi  
 
R 
48  Centipeda periodontii  163  Rothia aeria  
49  Corynebacterium durum  164  Rothia dentocariosa  
 
D 165  Rothia mucilaginosa  
50  Dialister invisus  166 
 Ruminococcus [G-1] bacterium HMT 
075  
 
E 167 
 Ruminococcus [G-2] bacterium HMT 
085  
51  Eikenella corrodens  
 
S 
 
F 168 
 Saccharibacteria (TM7) [G-1] 
bacterium HMT 346  
52  Filifactor alocis  169 
 Saccharibacteria (TM7) [G-1] 
bacterium HMT 347  
53  Finegoldia magna  170 
 Saccharibacteria (TM7) [G-1] 
bacterium HMT 348  
54  Fretibacterium sp. HMT 362  171 
 Saccharibacteria (TM7) [G-1] 
bacterium HMT 349  
55  Fusobacterium naviforme  172 
 Saccharibacteria (TM7) [G-1] 
bacterium HMT 352  
56  Fusobacterium nucleatum subsp. animalis  173 
 Saccharibacteria (TM7) [G-1] 
bacterium HMT 488  
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57  Fusobacterium nucleatum subsp. nucleatum  174 
 Saccharibacteria (TM7) [G-2] 
bacterium HMT 350  
58  Fusobacterium nucleatum subsp. polymorphum  175 
 Saccharibacteria (TM7) [G-3] 
bacterium HMT 351  
59  Fusobacterium nucleatum subsp. vincentii  176 
 Saccharibacteria (TM7) [G-5] 
bacterium HMT 356  
60  Fusobacterium periodonticum  177 
 Saccharibacteria (TM7) [G-6] 
bacterium HMT 870  
61  Fusobacterium sp. HMT 203  178 
 Saccharibacteria (TM7) [G-8] 
bacterium HMT 955  
62  Fusobacterium sp. HMT 370  179  Selenomonas dianae  
 
G 180  Selenomonas noxia  
63  Gemella haemolysans  181  Selenomonas sp. HMT 134  
64  Gemella morbillorum  182  Selenomonas sp. HMT 136  
65  Gemella sanguinis  183  Selenomonas sp. HMT 137  
66 
 Gracilibacteria (GN02) [G-1] bacterium HMT 
871  
184  Selenomonas sp. HMT 146  
67 
 Gracilibacteria (GN02) [G-1] bacterium HMT 
872  
185  Selenomonas sp. HMT 478  
68 
 Gracilibacteria (GN02) [G-2] bacterium HMT 
873  
186  Selenomonas sp. HMT 479  
69  Granulicatella adiacens  187  Selenomonas sputigena  
70  Granulicatella elegans  188  Shuttleworthia satelles  
 
H 189  Solobacterium moorei  
71  Haemophilus haemolyticus  190  Stomatobaculum longum  
72  Haemophilus parainfluenzae  191  Stomatobaculum sp. HMT 097  
73  Haemophilus paraphrohaemolyticus  192  Streptococcus anginosus  
74  Haemophilus pittmaniae  193  Streptococcus cristatus clade 578  
75  Haemophilus sp. HMT 036  194  Streptococcus gordonii  
76  Haemophilus sp. HMT 908  195  Streptococcus lactarius  
77  Haemophilus sputorum  196  Streptococcus mitis  
 
J 197  Streptococcus parasanguinis clade 411  
78  Johnsonella sp. HMT 166  198  Streptococcus peroris  
 
K 199  Streptococcus pneumoniae  
79  Kingella denitrificans  200  Streptococcus salivarius  
80  Kingella oralis  201  Streptococcus sanguinis  
81  Kingella sp. HMT 012  202  Streptococcus sinensis  
 
L 203  Streptococcus thermophilus  
82  Lachnoanaerobaculum orale  
 
T 
83  Lachnoanaerobaculum umeaense  204  Tannerella forsythia  
84  Lachnospiraceae [G-2] bacterium HMT 096  205  Tannerella sp. HMT 286  
85  Lactobacillus salivarius  206  Tannerella sp. HMT 808  
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86  Lautropia mirabilis  207  Treponema amylovorum  
87  Leptotrichia buccalis  208  Treponema denticola  
88  Leptotrichia hofstadii  209  Treponema lecithinolyticum  
89  Leptotrichia hongkongensis  210  Treponema maltophilum  
90  Leptotrichia shahii  211  Treponema medium  
91  Leptotrichia sp. HMT 212  212  Treponema parvum  
92  Leptotrichia sp. HMT 215  213  Treponema socranskii  
93  Leptotrichia sp. HMT 217  214  Treponema sp. HMT 231  
94  Leptotrichia sp. HMT 218  215  Treponema sp. HMT 237  
95  Leptotrichia sp. HMT 219  216  Treponema sp. HMT 249  
96  Leptotrichia sp. HMT 221  217  Treponema sp. HMT 258  
97  Leptotrichia sp. HMT 225  218  Treponema vincentii  
98  Leptotrichia sp. HMT 392  
 
U 
99  Leptotrichia sp. HMT 417  219 Uncultured 
100  Leptotrichia sp. HMT 463  
 
V 
101  Leptotrichia sp. HMT 498  220  Veillonella atypica  
104  Leptotrichia wadei  221  Veillonella denticariosi  
 
M 222  Veillonella dispar  
105  Megasphaera micronuciformis  223  Veillonella parvula  
106  Mycoplasma faucium  224  Veillonella rogosae  
 
N 225  Veillonella sp. HMT 780  
107  Neisseria cinerea  226  Veillonella sp. HMT 917  
108  Neisseria elongata  227 
 Veillonellaceae [G-1] bacterium HMT 
145  
109  Neisseria flava  228 
 Veillonellaceae [G-1] bacterium HMT 
155  
110  Neisseria flavescens  
  
 
O 
  
114  Oribacterium asaccharolyticum  
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GRAPH 1-A: BAR GRAPH DEMONSTRATING DISTRIBUTION OF 
BACTERIAL PHYLUM IN HEALTH AND IMPLANT 
 
 
GRAPH 1-B: BAR GRAPH DEMONSTRATING DISTRIBUTION OF 
BACTERIAL GENUS IN HEALTH AND IMPLANT 
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GRAPH 1-C: BAR GRAPH DEMONSTRATING DISTRIBUTION OF 
BACTERIAL SPECIES IN HEALTH AND IMPLANT 
53 
60 
48 50 52 54 56 58 60 62
HEALTH
IMPLANT
GENUS 
GENUS
                                                                       Tables and graphs 
 
 
 
 
GRAPH 2-A: TOP 5 PHYLUM IN HEALTH 
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GRAPH 2-B: TOP 5 PHYLA IMPLANT  
 
 
 
 
GRAPH 3-A: TOP 5 GENERA IN HEALTH 
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GRAPH 3-B: TOP 5 GENERA IN IMPLANT 
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TABLE 3-C: PHYLOGENETIC TREE AT GENUS LEVEL 
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DISCUSSION 
The simple presence of oral microbiota in the mouth inhibits colonisation by 
pathogens, the phenomenon of colonisation resistance. Because all surfaces of 
the mouth are colonised by commensals there are few binding sites available 
for pathogens 
121
.  
The human salivary microbiome may be a factor that plays a role in diseases 
of the oral cavity and interacts with microbiomes from other parts of the 
human body (in particular, the intestinal tract), but only little is known about 
normal variation in the salivary microbiome. The main reason for analyzing 
the human salivary microbiome is that since saliva is increasingly preferred for 
sampling in humans, as a source of DNA for epidemiologic and population 
genetic studies 
19
, it would be useful to identify bacterial taxa in saliva which 
in turn will be able to provide us with insights into human population structure 
and migrations.
 
Bacteria that normally reside in the oral cavity (i.e. the indigenous microbiota) 
can select from different ecosystems for their habitat.  Most pathogenic 
species (with the exception of spirochetes who limit themselves to the pocket) 
are able to colonise all five niches of the oral cavity 
28
.Some 
periodontopathogens (F. nucleatum and P. intermedia) are involved in the 
aetiology of tonsillitis, while others can even colonise the maxillary sinus. 
Since most pathogens are found in more than one niche, it is reasonable to 
assume that transmission occurs between these intra-oral niches (called 
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translocation) occurs. The existence of such a translocation was illustrated by 
Quirynen et al. in 1999
 79
. Such a translocation is made possible only in the 
presence of a fluid medium such as saliva. 
 
An inflammation that is of peri-implant origin usually represents the presence 
of a disease after the placement of a dental implant, which affects both the 
surrounding hard and soft tissue. Due to the high prevalence of peri-
implantitis, routine check-ups and evaluation along with elimination of risk 
factors (e.g. smoking, systemic diseases and specific continuous periodontitis) 
are recommended maintenance measures 
57
.  In addition to the different 
aspects involved in the process of osseointegration, the type and structure of 
the implant surface are also of importance 
27, 65
. For the treatment of peri-
implant disease conditions various conservative and surgical approaches can 
be utilised. This however recognises that treatment of peri-implantitis does not 
yield the same optimal results in terms of surgical and non-surgical 
management of periodontal diseases. 
The need for biomarker based assessment of peri-implant sites that are 
likely to undergo destruction is therefore great. 
There are hundreds of uncultivated bacterial species still remaining in 
the human oral cavity, and thus the role of the oral microbiome in health and 
disease is not yet fully understood. Previous studies which were conducted 
solely focused on the pathogens of teeth and implant and to explore the 
influence of implants on the oral microbiome. 
2
.  
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A number of in vitro studies have been published documenting the 
bacterial leakage along the interface at implant-abutment assemblies. 
Essentially, these indicated a bidirectional flux of fluids and bacteria via the 
microgap
 117
, which occurred within days following placement, at all implant 
types and implant-abutment configurations
 98.
 The phenomenon was reduced 
when the closing torque of the abutment screw was increased. 
In addition, more bacterial penetration was found along the transversal 
screw of screw-retained assemblies when compared with the microgap 
separating the implant from the abutment. 
In a study conducted by Lee KH et al
 58
 focused on exploring possible 
oral sources of species colonizing the oral cavity in patients with newly placed 
implants by comparing the pre and post implantation microbiota. Most of the 
microbial species were found on teeth and on the dorsum of the tongue before 
the implants were actually placed, indicating that there is an impact of the pre-
implant microbiota on microbial colonization of dental implants. This impact 
of the pre-implantation microbiota was also observed in three subjects that 
were colonized at relatively lower levels both before and after implant 
placement. The similarity of the bacterial samples obtained from the patients 
on the same visit from around the teeth and implants in partially dentate 
subjects indicate that the teeth are a likely source of implant species has 
previously been described (Shulman & Shepard 1989, Quirynen & 
Listgarten 1990, Meffert 1993, Mombelli et al. 1995)
 72
. It may also reflect a 
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similarity in chronology and quantity of plaque formation following the anti-
microbial regimen associated with implant surgery (Eke et al. 1995). 
Previous researchers have established that NGS technology is an open-
ended technique recognised for its high-throughput genomic analysis approach 
and its ability to quantify abundance of bacterial species. Its use has been 
applied in this study for sequencing the microbiome of unstimulated saliva 
samples from patients with implants placed in their oral cavity and 
periodontally healthy subjects. Illumina sequencing, being an advent of NGS 
technology has been utilised in this study as it provides more sequences per 
run, analyses a larger sample size, has a better assessment of the microbiome 
diversity, includes more bar-coded time points and samples, generates and 
sequences short 16S rRNA amplicons to determine even low abundance 
mtaxa.  
The V3-V4 region of 16S rRNA were used in this study because 
though V4 region provides a full overlap of two reads and reduces the noise in 
sequencing data thereby preventing OTU inflation but there is only less 
information contained within V4 region owing to its length (~255 base pairs) 
so a longer fragment such as the V3 which spans multiple hypervariable 
regions was also selected and is more suitable for distinguishing all bacterial 
species to genus level.
 
Subjects were periodontally evaluated and allocated into two groups as 
healthy controls (ten subjects) and patients with implants placed in their oral 
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cavity, six months after the loading of  the prostheses (ten subjects). Sterile 
containers with measurements were used to collect the unstimulated whole 
saliva samples based on the reliability as observed in earlier literature. In the 
experimental workflow, all reactions were carried out with water and plastic 
materials guaranteed as DNA-free to avoid contamination. 
The purpose of the study was to understand the salivary microbiome in 
an implant environment and since only a few studies have been conducted 
(Cássio do Nascimento et al) keeping this aim in mind, the study was taken 
up by our department. 
A vast diversity of salivary microflora and inter-individual variations 
among all samples were observed in our study. A total of 10 phyla, 53 genera 
and 187 species were observed in healthy sites; and11 phyla, 60 genera and 
228 species were found in the implant sites. 
When the  salivary microbiome was analysed at phylum level, with the 
top five phyla in healthy sites being phylum Firmicutes with the highest 
abundance of (28.63%) followed by Bacteroidetes (28.43%), Fusobacteria 
(15.9%), Proteobacteria (13.32%) and Actinobacter (6.56%), the results of 
our study fall in line with these earlier studies conducted by Egija Zaura 
Streptococcus, Selenomonas, Pectinatus and Cohnella also belong to 
the phylum Firmicutes. Our study also reports a higher abundance of 
Proteobacteria and Fusobacteria. Proteobacteria phylum comprises of species 
such as Campylobacter, Kingella, Eikenella and Neisseria and Fusobacteria 
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phylum comprises genera Fusobacterium and Leptotriciae; all of which are 
known to be early colonisers. 
In implant sites, the top five phyla are phylum Firmicutes (31.7%) 
which has shown the highest abundance of 31.7% followed by Bacteroidetes 
(26.1%), Fusobacteria (15.49%), Proteobacteria 9.23 % and TM7 (7.33%). In 
a study conducted by Cássio do Nascimento et al which was similar to the 
our study, it was observed that the most prevalent species found in patients 
with titanium implants were the Gram-negative bacteria belonging mainly to 
the phylum Proteobacteira, which includes the Neisseriaceae and 
Campylobacteraceae families, followed by the phyla Firmicutes and 
Actinobacteria and Bacteroidetes, this correlates with the results of our study. 
The only phyla that was absent in healthy samples was Synergistetes.  Studies 
were conducted by Sonia R. Vartoukian in which Synergistetes was cultured 
to obtain a new genus Fretibacterium and the new species Fretibacterium 
fastidiosum in 2009
 120
. The cells are asaccharolytic and major amounts of 
acetic acid and moderate amounts of propionic acid are produced as end 
products of metabolism in peptone-yeast extract-glucose broth supplemented 
with a filtered cell sonicate of Fusobacterium nucleatum. 
At genus level, Prevotella was the predominant genus among both the 
healthy sites (12.82%) and implant sites (12.4%) this correlates with the study 
conducted by Daniel Blestorm. The genus Neisseria and Eikenella were 
found to be more abundant in the study conducted by Cássio do Nascimento 
et al. Following this is Leptotrichia with values of 9.14% and 9.23% 
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respectively, the next four genera in healthy sites are Fusobacterium (6.75%), 
Veillonella (6.26%), Porphyromonas (5.16%) and Nisseria (4.97%) and in 
implant sites are Saccharibacteria (6.61%), Fusobacterium (6.15%), 
Porphyromonas (5.52%) and Veillonella (5.52%). This correlates with the 
results from previous studies conducted by Sonia R. Vartoukian. 
 The genera found in healthy samples that were not in implant 
samples were: Adlercreutzia, Anaerococcus, Bergeyella, Clostridiales, 
Johnsonella, Odoribacter, Johnsonella, Pyramidobacter, Scardovia, 
Sporanaerobacter. The genera found in patient with implants that were not 
present in healthy patients are: Absconditabacteria, Anaerovorax, Eggerthella, 
Erwinia, Novosphingobium, Slackia. 
A total of 187 species were identified in health and 228 species 
identified in implants. Among the top 15 species found in both healthy and 
implant patients, Porphyromonas pasteri showed the highest abundance of 
2.68% in health and and 2.81% in implant this was followed by 
Fusobacterium nucleaum subsp. vincentii this correlated with the results based 
on a comparative study conducted between zirconia and titanium implants, in 
which the titanium implants showed the presence of Fusobacterium nucleatum 
species more predominantly.  
At species level, the top 15 species in healthy samples were 
Porphyromonas pasteri (2.68%) Fusobacterium nucleatum subsp. Vincentii 
(2.18%),Veillonella parvula (1.59%)  Capnocytophaga sputigena (1.49%), 
Alloprevotella sp. HMT 473 (1.19%) Prevotella veroralis (1.19%), 
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Fusobacterium periodonticum (1.09%) Bergeyella sp. HMT 322 (0.99%), 
Campylobacter concisus (0.99%) Fusobacterium sp. HMT 370 (0.99%), 
Gemella haemolysins (0.99%), Gemella morbillorum (0.99%), Gemella 
sanguine( 0.99%),  Granulicatella adiacens( 0.99%), Haemophilus 
parainfluenzae (0.99%)  
The top 15 bacterial species found in implants related sites were: 
Porphyromonas pasteri (2.8%), Fusobacterium nucleatum subsp. Vincentii 
(1.99%), Capnocytophaga sputigena (1.35%) Veillonella parvula (1.35%) 
Capnocytophaga leadbetteri (1.17%), Capnocytophaga granulosa (1.086%) 
Megasphaera micronuciformis (0.99%), Catonella morbi (0.90%) 
Fusobacterium periodonticum (0.90%), Gemella morbillorum (0.90%), 
Granulicatella adiacens (0.90%), Haemophilus parainfluenzae (0.90%) 
Leptotrichia hofstadii (0.90%), Oribacterium parvum (0.90%),  Prevotella sp. 
HMT 313 (0.90%). These results were in contrast to the results obtained in the 
st kudy conducted by Jan Cosyn et al, in which it was found that the speices 
with highest abundance in implants was for Fusobacterium periodonticum 
followed by Fusobacterium nucleatum sp. Nucleatum. 
Species found exclusively in healthy samples: Acinetobacter johnsonii 
Actinomyces sp. HMT 175, Aggregatibacter paraphrophilus, Aggregatibacter 
sp. HMT 513, Bifidobacterium animalis, Capnocytophaga sp HMT 878, 
Eggerthella lenta, Enterobactercancerogenus, Enterococcus casseliflavus, 
Enterococcus saccharolyticus, Filifactor alocis, Gemella bergeri, 
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Haemophilus influenzae Kingella sp. HMT 932 , Klebsiella aerogenes, 
Lactobacillus crispatus, Novosphingobium panipatense, 
Peptostreptococcaceae [XI][G-5] bacterium HMT 493, Prevotella sp. HMT 
304, Slackia exigua 
Apart from this species found exclusively in implant related samples 
were: Actinomyces oris ,Actinomyces sp. HMT 169 ,Anaerococcus octavius, 
Bacteroides heparinolyticus,Bacteroidetes [G-3] bacterium HMT 280, 
Bacteroidetes [G-3] bacterium HMT 436, Bacteroidetes [G-5] bacterium 
HMT 505 , Bacteroidetes [G-6] bacterium HMT 516,Bulleidia extructa, 
Butyrivibrio sp. HMT 080, Capnocytophaga sp. HMT 324, Capnocytophaga 
sp. HMT 338, Clostridiales [F-1][G-1] bacterium HMT 093, Dialister 
pneumosintes, Enterococcus faecalis, Fretibacterium fastidiosum, 
Fretibacterium sp. HMT 360, etc  as stated in the results. 
 This in turn led to the conclusion that a distinct health-associated 
salivary microbiome and implant-associated salivary microbiome were 
identified.  
Based on previous studies conducted by Cortelli S 
20
 it is proven that a 
previous history of periodontitis may imply a condition of peri-implantitis in 
the future, thereby establishing a relationship between periodontal disease and 
peri-implant conditions.  
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Limitations of the study: 
Due to the presence of vast numbers of uncultured species that have not 
been accounted for by the HOMI database, there are still a lot of 
microorganisms that we are unaware of and these microorganisms may be one 
of the key pathogens that are involved in the pathogenesis of disease.  
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SUMMARY AND CONCLUSION 
 This study characterized salivary microbiome in patients with dental 
endosseous implants placed in their oral cavity (6 months post loading). Ten 
unstimulated whole salivary samples obtained from patients with implants 
placed in their oral cavity (6 months post loading)  and ten samples from 
periodontally healthy were collected and microbiome characterization was 
done using NGS technology using Illumina sequencing. 
 A wide array of microbes were identified in health and implant 
belonging to a complex community structure comprising 10 phyla, 53 genus, 
187 species in healthy subjects and 11 phyla, 60 genus and 228 species in the 
implant patients. 
            Both the health and implant samples showed a higher abundance value 
for Fusobacterium nucleatum and Veillonella species, which are the initial 
colonisers. The phyla Firmicutes is found to be the highest in both implant and 
healthy samples and the Genera Prevetolla was found have the highest 
abundance in both implant and healthy samples. At the species level 
Porphyromonas pasteri was observed to have the highest abundance in both 
implant and healthy samples. 
            A distinct salivary microbiome is found in implant samples when 
compared to healthy samples. Further studies need to be done to identify the 
role of these bacteria in periodontal health and implant patients. 
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ANNEXURE III 
CONSENT FORM 
 
I ……………………………………………………S/o, w/o, 
d/o……………………… 
 aged about ……………….years, Hindu/Christian/Muslim 
……………………………… ………….residing at 
…………………………………………………………………………do 
solemnly   
And state as follows. 
I am the deponent herein; as such I am aware of the facts stated here 
under 
I state that I came to Ragas Dental College and Hospital, Chennai for 
my treatment for 
…………………………………………………………………………………
…………………………… 
I was examined by Dr……………………………………….. and I was 
requested to do the following  
1. Full mouth Plaque Score 
2. Full mouth bleeding score 
3 Measurement of periodontal pocket depth and clinical attachment loss 
I was also informed and explained about the collection of plaque 
during scaling in …………………………………(language) known to me. 
Annexures 
  
 
 
I was also informed and explained that the results of the individual test 
will not  be revealed to the public. I give my consent after knowing full 
consequence of the dissertation/thesis/study and I undertake to cooperate with 
the doctor for the study. 
I also authorise the Doctor to proceed with further treatment or any 
other suitable alternative method for the study, 
I have given voluntary consent to the collection of plaque for approved 
research. 
 I am also aware that I am free to withdraw the consent given at any 
time during the study in writing. 
Signature of the patient/Attendant 
    
The patient was explained the procedure by me and has understood the 
same and with full consent signed in 
(English/Tamil/Hindi/Telugu?.............................) before me 
 
Signature of the Doctor 
 
